<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">64456</article-id><article-id pub-id-type="doi">10.7554/eLife.64456</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>TDP-43 maximizes nerve conduction velocity by repressing a cryptic exon for paranodal junction assembly in Schwann cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-213847"><name><surname>Chang</surname><given-names>Kae-Jiun</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3656-7725</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213848"><name><surname>Agrawal</surname><given-names>Ira</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2195-6090</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-68437"><name><surname>Vainshtein</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-119476"><name><surname>Ho</surname><given-names>Wan Yun</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213849"><name><surname>Xin</surname><given-names>Wendy</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-1425-834X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-92996"><name><surname>Tucker-Kellogg</surname><given-names>Greg</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-213850"><name><surname>Susuki</surname><given-names>Keiichiro</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-38924"><name><surname>Peles</surname><given-names>Elior</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund10"/><xref ref-type="other" rid="fund11"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-213851"><name><surname>Ling</surname><given-names>Shuo-Chien</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0300-8812</contrib-id><email>phsling@nus.edu.sg</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund13"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-153251"><name><surname>Chan</surname><given-names>Jonah R</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2176-1242</contrib-id><email>Jonah.Chan@ucsf.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund14"/><xref ref-type="other" rid="fund9"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Neurology, Weill Institute for Neurosciences, University of California, San Francisco</institution><addr-line><named-content content-type="city">San Francisco</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Department of Physiology, National University of Singapore</institution><addr-line><named-content content-type="city">Singapore</named-content></addr-line><country>Singapore</country></aff><aff id="aff3"><label>3</label><institution>Department of Molecular Cell Biology, Weizmann Institute of Science</institution><addr-line><named-content content-type="city">Rehovot</named-content></addr-line><country>Israel</country></aff><aff id="aff4"><label>4</label><institution>Department of Biological Sciences, and Computational Biology Programme, Faculty of Science, National University of Singapore</institution><addr-line><named-content content-type="city">Singapore</named-content></addr-line><country>Singapore</country></aff><aff id="aff5"><label>5</label><institution>Department of Neuroscience, Cell Biology, and Physiology, Boonshoft School of Medicine, Wright State University</institution><addr-line><named-content content-type="city">Dayton</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution>NUS Medicine Healthy Longevity Program, National University of Singapore</institution><addr-line><named-content content-type="city">Singapore</named-content></addr-line><country>Singapore</country></aff><aff id="aff7"><label>7</label><institution>Program in Neuroscience and Behavior Disorders, Duke-NUS Medical School</institution><addr-line><named-content content-type="city">Singapore</named-content></addr-line><country>Singapore</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Bergles</surname><given-names>Dwight E</given-names></name><role>Reviewing Editor</role><aff><institution>Johns Hopkins University School of Medicine</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Westbrook</surname><given-names>Gary L</given-names></name><role>Senior Editor</role><aff><institution>Oregon Health and Science University</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>10</day><month>03</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e64456</elocation-id><history><date date-type="received" iso-8601-date="2020-10-29"><day>29</day><month>10</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-02-25"><day>25</day><month>02</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Chang et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Chang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-64456-v1.pdf"/><abstract><p>TDP-43 is extensively studied in neurons in physiological and pathological contexts. However, emerging evidence indicates that glial cells are also reliant on TDP-43 function. We demonstrate that deletion of TDP-43 in Schwann cells results in a dramatic delay in peripheral nerve conduction causing significant motor deficits in mice, which is directly attributed to the absence of paranodal axoglial junctions. By contrast, paranodes in the central nervous system are unaltered in oligodendrocytes lacking TDP-43. Mechanistically, TDP-43 binds directly to <italic>Neurofascin</italic> mRNA, encoding the cell adhesion molecule essential for paranode assembly and maintenance. Loss of TDP-43 triggers the retention of a previously unidentified cryptic exon, which targets <italic>Neurofascin</italic> mRNA for nonsense-mediated decay. Thus, TDP-43 is required for neurofascin expression, proper assembly and maintenance of paranodes, and rapid saltatory conduction. Our findings provide a framework and mechanism for how Schwann cell-autonomous dysfunction in nerve conduction is directly caused by TDP-43 loss-of-function.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>TDP-43</kwd><kwd>Schwann cell</kwd><kwd>myelination</kwd><kwd>node of Ranvier</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R01NS062796</award-id><principal-award-recipient><name><surname>Chan</surname><given-names>Jonah R</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R01NS097428</award-id><principal-award-recipient><name><surname>Chan</surname><given-names>Jonah R</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R01NS095889</award-id><principal-award-recipient><name><surname>Chan</surname><given-names>Jonah R</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100005984</institution-id><institution>Dr. Miriam and Sheldon G. Adelson Medical Research Foundation</institution></institution-wrap></funding-source><award-id>APND grant A130141</award-id><principal-award-recipient><name><surname>Chan</surname><given-names>Jonah R</given-names></name></principal-award-recipient></award-group><award-group id="fund14"><funding-source><institution-wrap><institution>Rachleff Family Endowment</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Chan</surname><given-names>Jonah R</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001349</institution-id><institution>National Medical Research Council</institution></institution-wrap></funding-source><award-id>NMRC/OFIRG/0001/2016</award-id><principal-award-recipient><name><surname>Ling</surname><given-names>Shuo-Chien</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001349</institution-id><institution>National Medical Research Council</institution></institution-wrap></funding-source><award-id>NMRC/OFIRG/0042/2017</award-id><principal-award-recipient><name><surname>Ling</surname><given-names>Shuo-Chien</given-names></name></principal-award-recipient></award-group><award-group id="fund13"><funding-source><institution-wrap><institution>Swee Liew-Wadsworth Endowment fund</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Ling</surname><given-names>Shuo-Chien</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003977</institution-id><institution>Israel Science Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Peles</surname><given-names>Elior</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100005984</institution-id><institution>Dr. Miriam and Sheldon G. Adelson Medical Research Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Peles</surname><given-names>Elior</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R01NS107398</award-id><principal-award-recipient><name><surname>Susuki</surname><given-names>Keiichiro</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>R03NS112981</award-id><principal-award-recipient><name><surname>Susuki</surname><given-names>Keiichiro</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000890</institution-id><institution>National Multiple Sclerosis Society</institution></institution-wrap></funding-source><award-id>FG-1507-05195</award-id><principal-award-recipient><name><surname>Chang</surname><given-names>Kae-Jiun</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Glial TDP-43 regulates splicing and expression of neurofascin and is required for proper assembly and maintenance of paranodal axoglial junctions.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>TDP-43 (transactivation response DNA-binding protein of 43 kDa, encoded by <italic>Tardbp</italic>) is a nucleic acid-binding protein that regulates the processing of a wide range of coding and noncoding RNAs by directly binding to transcripts and/or interacting with key RNA-processing complexes (<xref ref-type="bibr" rid="bib15">Ederle and Dormann, 2017</xref>; <xref ref-type="bibr" rid="bib36">Ling et al., 2013</xref>). TDP-43 binds to more than 6000 RNA targets in the brain (<xref ref-type="bibr" rid="bib53">Polymenidou et al., 2011</xref>; <xref ref-type="bibr" rid="bib69">Tollervey et al., 2011</xref>)—roughly 30% of the total transcriptome—and modulates target gene expression by regulating mRNA stability, splicing, polyadenylation site selection, transport, and translation (<xref ref-type="bibr" rid="bib15">Ederle and Dormann, 2017</xref>; <xref ref-type="bibr" rid="bib36">Ling et al., 2013</xref>; <xref ref-type="bibr" rid="bib56">Rot et al., 2017</xref>). As such, TDP-43 is a multifunctional master gene regulator with numerous potential targets as its downstream effectors. The detection of TDP-43-containing pathological aggregates in numerous neurodegenerative diseases—including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia—has resulted in the classification of a spectrum of disorders known as TDP-43 proteinopathies (<xref ref-type="bibr" rid="bib33">Kwong et al., 2008</xref>; <xref ref-type="bibr" rid="bib36">Ling et al., 2013</xref>). It is widely considered that both loss of function and gain of toxic properties may contribute to the neurodegeneration associated with TDP-43 proteinopathies (<xref ref-type="bibr" rid="bib36">Ling et al., 2013</xref>). Therefore, it is of critical importance to gain a better understanding of the physiological functions for TDP-43.</p><p>Not surprisingly, the function of TDP-43 is mainly focused in neurons (<xref ref-type="bibr" rid="bib28">Iguchi et al., 2013</xref>; <xref ref-type="bibr" rid="bib32">Klim et al., 2019</xref>; <xref ref-type="bibr" rid="bib38">Melamed et al., 2019</xref>; <xref ref-type="bibr" rid="bib68">Tann et al., 2019</xref>; <xref ref-type="bibr" rid="bib72">Wu et al., 2012</xref>). However, emerging evidence indicates that the functional roles for TDP-43 are not limited to neurons, but that glial cells are also reliant on TDP-43 function and may play a role in pathogenesis (<xref ref-type="bibr" rid="bib44">Paolicelli et al., 2017</xref>; <xref ref-type="bibr" rid="bib48">Peng et al., 2020</xref>; <xref ref-type="bibr" rid="bib70">Velebit et al., 2020</xref>; <xref ref-type="bibr" rid="bib71">Wang et al., 2018</xref>). Intriguingly, it is known that the cells of the peripheral nervous system (PNS) are also affected in ALS patients with differential vulnerability (<xref ref-type="bibr" rid="bib25">Gentile et al., 2019</xref>), calling for a better understanding of a potential cell-autonomous role for TDP-43 in various PNS cell types. Therefore, we decided to investigate the physiological role of TDP-43 in the main glial cell type of the PNS, namely the Schwann cell (<xref ref-type="bibr" rid="bib62">Stierli et al., 2018</xref>). Schwann cells ensheathe and myelinate all relevant axons of the peripheral nerves (<xref ref-type="bibr" rid="bib41">Nave and Werner, 2014</xref>; <xref ref-type="bibr" rid="bib58">Salzer, 2015</xref>). Moreover, Schwann cell–axon interactions highly cluster voltage-gated sodium (Nav) channels at nodes of Ranvier, thus enabling rapid saltatory conduction (<xref ref-type="bibr" rid="bib52">Poliak and Peles, 2003</xref>; <xref ref-type="bibr" rid="bib57">Salzer, 2003</xref>). The intricate interactions between axons and Schwann cells further establish the paranodal axoglial junctions that flank nodes of Ranvier and are essential for the maximal insulatory function of myelin (<xref ref-type="bibr" rid="bib46">Pedraza et al., 2001</xref>; <xref ref-type="bibr" rid="bib55">Rosenbluth, 2009</xref>). Given the pivotal role Schwann cells play in the physiology of the PNS, we investigated the function of TDP-43 in Schwann cells. In mice lacking TDP-43 in Schwann cells, we find a 50% delay in nerve conduction with motor deficits, without any apparent structural alteration in compact myelin. Further analysis reveals a specific disruption in the assembly of paranodal junctions, directly resulting in conduction delay. This deficit is exclusive to Schwann cells and not observed in oligodendrocyte paranodes in the central nervous system (CNS). Furthermore, we find that TDP-43 is required for the expression of <italic>Neurofascin</italic> (<italic>Nfasc</italic>), which encodes a glial cell adhesion molecule necessary for paranodal junction formation and maintenance, by repressing the usage of a cryptic exon during splicing. Our findings are the first demonstration of a functional role for TDP-43 in axon–glial interactions in the PNS and that the loss of function for TDP-43 in Schwann cells results in impaired conduction velocity and motor behavior.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Schwann cell TDP-43 is required for rapid nerve conduction but not for myelination</title><p>TDP-43 is abundantly expressed by all Sox10-positive Schwann cells (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A, B</xref>). To elucidate the PNS-autonomous function of TDP-43, we specifically ablated TDP-43 from Schwann cells by combining the TDP-43 conditional allele (<italic>Tardbp<sup>fl/fl</sup></italic>) (<xref ref-type="bibr" rid="bib9">Chiang et al., 2010</xref>) with <italic>Dhh-Cre</italic> (<xref ref-type="bibr" rid="bib29">Jaegle et al., 2003</xref>). In these conditional knockout (cKO) mice, TDP-43 expression is completely abolished in Schwann cells (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). By measuring the motor nerve conduction velocity, we find that action potential propagation is delayed by ~50% in the cKO mice at postnatal day (P) 27 (<xref ref-type="fig" rid="fig1">Figure 1A, C</xref>). However, the cKO sciatic nerves appear normal in size and opacity compared to wild-type (WT) nerves (<xref ref-type="fig" rid="fig1">Figure 1D</xref>), suggesting that compact myelin is being formed normally. To confirm the extent of myelination, we examined the sciatic nerves by electron microscopy. While a slight decrease in the number of myelinated axons is observed in the cKO nerves at P3, they recover to control levels by P21 (<xref ref-type="fig" rid="fig1">Figure 1E, F</xref>) with myelin thickness comparable to the WT (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). Taken together, these results demonstrate that Schwann cell TDP-43 is required for normal nerve conduction velocity, despite the normal appearance of compact myelin in the TDP-43-cKO mice.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Knockout of TDP-43 in Schwann cells results in a 50% conduction delay without overt alteration of compact myelin.</title><p>(<bold>A</bold>) Longitudinal sections of P28 wild-type (WT) and conditional knockout (cKO) sciatic nerves were immunostained for TDP-43 (green) and Sox10 (magenta). Sox10 labels Schwann cells, which are all TDP-43-negative in the cKO. The cell types other than Schwann cells are Sox10-negative and are still TDP-43-positive in the cKO. Scale bar, 10 μm. (<bold>B, C</bold>) Motor nerve conduction of P27 mice was measured as compound muscle action potentials at the plantar muscles evoked by stimulation of the nerve at the ankle and sciatic notch. The onset of the compound muscle action potentials is indicated by open arrowheads (ankle stimulation) and solid arrowheads (sciatic notch stimulation) in <bold>B</bold>. Bars represent mean ± SEM in <bold>C</bold>. n = 5 mice for WT, 3 for conditional heterozygote (cHet), and 3 for cKO. **p=0.0030 and 0.0028 (WT vs. cKO and cHet vs. cKO, respectively); ns: not significant, p=0.8094 (WT vs. cHet); one-way analysis of variance (ANOVA) with Tukey’s test. (<bold>D</bold>) Sciatic nerves from P7 WT and cKO mice. (<bold>E</bold>) The number of myelinated axons per 1000 μm² was quantified with electron micrographs of sciatic nerve cross sections. Bars represent mean ± SEM. n = 3 mice per genotype. *p=0.039 and 0.048 (WT vs. cKO and cHet vs. cKO at P3, respectively); ns: not significant (WT vs. cHet at P3, p=0.9812; P21, p=0.5381); one-way ANOVA with Tukey’s test. (<bold>F</bold>) Electron micrographs of P3 and P21 sciatic nerve cross sections. Scale bars, 2 μm for P3 and 5 μm for P21. cHet and cKO by <italic>Dhh-Cre</italic> (<bold>A–F</bold>).</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig1">Figure 1C, E</xref> and <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64456-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64456-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>TDP-43 is expressed by wild-type (WT) Schwann cells and specifically ablated from the conditional knockout (cKO) Schwann cells.</title><p>(<bold>A</bold>) Single-channel images and the merged image with DAPI nuclear staining for <xref ref-type="fig" rid="fig1">Figure 1A</xref>. Scale bar, 10 μm. (<bold>B</bold>) Immunostaining of P3 WT and cKO sciatic nerves for TDP-43 (green) and Sox10 (red). Sox10 labels Schwann cells, which are all TDP-43-negative in the cKO. The cell types other than Schwann cells are Sox10-negative and are still TDP-43-positive in the cKO. Scale bar, 10 μm. (<bold>C</bold>) Immunostaining of P28 WT and cKO sciatic nerves for TDP-43 (green), PDGFRα (red), and DAPI (blue). PDGFRα labels endoneurial fibroblasts, which are TDP-43-positive in the cKO. Scale bar, 10 μm. cKO by <italic>Dhh-Cre</italic> (<bold>A–C</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64456-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Quantification for the myelin thickness and axon diameters of myelinated axons in the TDP-43-cKO sciatic nerves.</title><p>(<bold>A</bold>) The scatter plot showing the g-ratios (y-axis) in relation to the axon diameters (x-axis) of individual myelinated axons in P21 wild-type (WT) and conditional knockout (cKO) sciatic nerves. The g-ratio was calculated as axon diameter/(axon diameter + myelin thickness ×2). Average g-ratios (mean ± SEM): WT = 0.6809 ± 0.0066; cKO = 0.6640 ± 0.0009. Unpaired two-tailed <italic>t</italic>-test: p=0.1214. (<bold>B</bold>) The histogram showing the frequency of different axon populations in each axon diameter range. n = 3 mice (totally 415 axons) for WT; n = 3 mice (totally 376 axons) for cKO. More than 100 axons per mouse were analyzed.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64456-fig1-figsupp2-v1.tif"/></fig></fig-group></sec><sec id="s2-2"><title>Paranodal junctions are not formed in the PNS of TDP-43-cKO mice</title><p>If compact myelin is unaltered, then what mechanism underlies the conduction delay in the TDP-43-cKO nerves? Paranodal axoglial junctions serve as a multifunctional diffusion barrier that is required for maximal axon insulation provided by myelin sheaths (<xref ref-type="bibr" rid="bib46">Pedraza et al., 2001</xref>; <xref ref-type="bibr" rid="bib55">Rosenbluth, 2009</xref>). Mouse mutants lacking paranodal junctions display an ~40–50% delay in nerve conduction without gross myelination defects (<xref ref-type="bibr" rid="bib5">Bhat et al., 2001</xref>; <xref ref-type="bibr" rid="bib49">Pillai et al., 2009</xref>; <xref ref-type="bibr" rid="bib65">Susuki et al., 2013</xref>). Therefore, we tested the hypothesis that conduction delay in the TDP-43-cKO nerves may be due to a defect in paranodal junctions. Paranodal junctions comprise three key cell adhesion molecules—axonal Caspr (contactin-associated protein), axonal contactin (Cntn), and glial neurofascin (NFasc) 155 kDa isoform (NF155), each of which is essential for paranodal junction formation (<xref ref-type="bibr" rid="bib52">Poliak and Peles, 2003</xref>; <xref ref-type="bibr" rid="bib57">Salzer, 2003</xref>). In the mature WT PNS, Nav channels and axonal 186 kDa isoform of NFasc (NF186) are enriched at nodes of Ranvier, whereas NF155 and Caspr/Cntn are highly clustered at paranodal domains flanking each node (<xref ref-type="fig" rid="fig2">Figure 2A, B</xref> [nodes indicated by open arrowheads and paranodes by solid arrowheads], <xref ref-type="fig" rid="fig2">Figure 2C</xref>). In stark contrast to the WT and conditional heterozygote (cHet), the prototypical Caspr clustering is no longer detected at paranodes in the cKO at P28 (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) and neither are Cntn, NF155, and the NF155-associated scaffold protein AnkB (<xref ref-type="bibr" rid="bib7">Chang et al., 2014</xref>; <xref ref-type="fig" rid="fig2">Figure 2B–D</xref>), indicating that paranodal junctions are disrupted in the TDP-43 cKO. To determine whether paranodal junctions are not assembled during early development in the TDP-43 cKO or are initially formed but not stabilized during and after myelination, we examined P3 sciatic nerves (initiation of myelination) and found that Caspr is absent at paranodes while the Schwann cell-secreted extracellular matrix component gliomedin (Gldn) (<xref ref-type="bibr" rid="bib17">Eshed et al., 2005</xref>) remains clustered at nascent nodes (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). This strongly suggests that paranodal junctions fail to form starting from the initiation of myelination in the absence of Schwann cell TDP-43.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Paranodal axoglial junctions are disrupted in the TDP-43-cKO mice.</title><p>(<bold>A</bold>) Immunostaining of P28 sciatic nerves for contactin-associated protein (Caspr) (green, paranode) and Nav channels (panNav, magenta, node). (<bold>B–D</bold>) Immunostaining of P28 sciatic nerves for (<bold>B</bold>) neurofascin (NFasc) (magenta, node and paranode) and Caspr (green), (<bold>C</bold>) contactin (Cntn, magenta, paranode) and NFasc (green), and (<bold>D</bold>) ankyrinB (AnkB, green, paranode) and ankyrinG (AnkG, magenta, node). Nodes are indicated by open arrowheads in <bold>B</bold>. Paranodes are indicated by solid arrowheads in <bold>B, D</bold>. (<bold>E</bold>) Immunostaining of P3 sciatic nerves for Caspr (green) and gliomedin (Gldn, magenta, node). (<bold>F</bold>) Immunostaining of P28 sciatic nerves for Kv1.1 channels (green, juxtaparanode), Caspr (red), and NFasc (blue). (<bold>G</bold>) Electron micrographs of P21 sciatic nerve longitudinal sections. (<bold>H</bold>) The time periods for which the mice remained on the rotarod at 24 or 32 rpm. Minima, first quartiles, medians, third quartiles, and maxima are plotted as box-and-whisker plots. n = 10 mice per genotype. *p=0.0115 for 24 rpm; **p=0.0036 for 32 rpm; Mann–Whitney tests. Scale bars, 5 μm (<bold>A–F</bold>) and 200 nm (<bold>G</bold>). Conditional heterozygote (cHet) and conditional knockout (cKO) by <italic>Dhh-Cre</italic> in (<bold>A–C</bold>) and (<bold>E–G</bold>), and by <italic>Mpz-Cre</italic> in (<bold>D, H</bold>).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig2">Figure 2H</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64456-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64456-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Paranodal axoglial junctions are completely disrupted in the peripheral nervous system of the TDP-43-cKO mice using three different Cre-driver lines.</title><p>(<bold>A–C</bold>) Immunostaining of P28 sciatic nerves for (<bold>A</bold>) neurofascin (NFasc) (red), Kv1.2 channels (green, juxtaparanode), and Nav channels (panNan) (cyan); (<bold>B</bold>) contactin-associated protein (Caspr) (green), contactin (Cntn) (red), and Kv1.1 channels (blue); and (<bold>C</bold>) Caspr (magenta) and Caspr2 (green, juxtaparanode). Conditional heterozygote (cHet) and conditional knockout (cKO) by <italic>Mpz-Cre</italic> (<italic>P0-Cre</italic>). Scale bars, 5 μm. (<bold>D, E</bold>) Immunostaining of P60 sciatic nerves for (<bold>D</bold>) Caspr (green), NFasc (blue), and Nav channels (panNav) (red); and (<bold>E</bold>) NFasc (magenta) and Kv1.1 channels (green). cHet and cKO by <italic>Cnp-Cre</italic>. Scale bars, 2 μm (<bold>D</bold>) and 5 μm (<bold>E</bold>). (<bold>F, G</bold>) Immunostaining of P28 trigeminal nerves for (<bold>F</bold>) Caspr (red), gliomedin (Gldn) (green), and βIV spectrin (blue, node); and (<bold>G</bold>) NFasc (green) and Kv1.2 channels (magenta). cHet and cKO by <italic>Dhh-Cre</italic>. Scale bars, 5 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64456-fig2-figsupp1-v1.tif"/></fig></fig-group><p>One hallmark alteration of losing the diffusion barrier function exerted by paranodal junctions is translocation of the <italic>Shaker</italic>-type voltage-gated potassium (Kv1) channels and their associated protein complex from juxtaparanodal regions to paranodes (<xref ref-type="bibr" rid="bib52">Poliak and Peles, 2003</xref>; <xref ref-type="bibr" rid="bib57">Salzer, 2003</xref>). In WT nerves, Kv1.1 and Kv1.2 channels and Caspr2 are concentrated in the juxtaparanodal domains and separated from nodes of Ranvier by paranodal junctions (<xref ref-type="fig" rid="fig2">Figure 2F</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–C</xref>). Strikingly, in the cKO sciatic nerves these components invade the paranodes (<xref ref-type="fig" rid="fig2">Figure 2F</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–C</xref>). By examining trigeminal nerves and using two alternative Cre-driver lines—<italic>Mpz-Cre</italic> for Schwann cells (<xref ref-type="bibr" rid="bib21">Feltri et al., 1999</xref>; <xref ref-type="bibr" rid="bib22">Feltri et al., 2002</xref>) and <italic>Cnp-Cre</italic> for both Schwann cells and oligodendrocytes (<xref ref-type="bibr" rid="bib34">Lappe-Siefke et al., 2003</xref>)—we consistently identify the complete loss of paranodal junctions and translocation of the Kv1 complex to paranodes in the TDP-43 cKO (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Ultrastructurally, the paranodal loops in the cKO detach from the axons. The loops are no longer tightly apposed to the axon, resulting in the absence of the clear indentation of the axolemma, typically observed in WT nerves (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). Taken together, our findings strongly suggest a cell-autonomous role of Schwann cell TDP-43 in assembling paranodal junctions and properly establishing the polarized molecular domains at nodes of Ranvier.</p><p>Mutant mice lacking paranodal junctions in both the PNS and CNS exhibit tremors, paralysis, and ataxia (<xref ref-type="bibr" rid="bib4">Berglund et al., 1999</xref>; <xref ref-type="bibr" rid="bib5">Bhat et al., 2001</xref>; <xref ref-type="bibr" rid="bib10">Coetzee et al., 1996</xref>; <xref ref-type="bibr" rid="bib49">Pillai et al., 2009</xref>). Despite the lack of paranodal junctions in the PNS, the TDP-43-cKO mice (by <italic>Dhh-Cre</italic> or <italic>Mpz-Cre</italic>) do not exhibit a gross neurological deficit when observed in their home cage. However, when challenged with the rotarod test, the cKO mice perform significantly worse than WT littermates (<xref ref-type="fig" rid="fig2">Figure 2H</xref>), suggesting that PNS paranodal junctions are required for optimal motor performance.</p></sec><sec id="s2-3"><title>Paranodal junctions are formed in the CNS of TDP-43-cKO mice</title><p>Given that paranodal junction assembly in both the PNS and CNS requires Caspr, Cntn, and NF155 (<xref ref-type="bibr" rid="bib52">Poliak and Peles, 2003</xref>; <xref ref-type="bibr" rid="bib57">Salzer, 2003</xref>), we set out to determine whether TDP-43 in oligodendrocytes is also essential for establishing axoglial junctions in the CNS. Although TDP-43 ablation in oligodendrocytes by <italic>Cnp-Cre</italic> causes necroptosis of mature oligodendrocytes (<xref ref-type="bibr" rid="bib71">Wang et al., 2018</xref>), many myelin internodes exist in the CNS, which are formed by oligodendrocytes prior to degeneration. Surprisingly, Caspr clusters are still clearly detected in the cKO spinal cords (<xref ref-type="fig" rid="fig3">Figure 3A, B</xref>), indicating that TDP-43 is dispensable for CNS paranodal junction formation. The dramatic difference in the requirement for TDP-43 between the PNS and CNS is highlighted at the dorsal root transition zone, where the paranodal junctions fail to form exclusively on the PNS side in the cKO and not on the CNS side (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Knockout of TDP-43 in oligodendrocytes displays normal paranodal axoglial junctions in the central nervous system (CNS).</title><p>(<bold>A</bold>) Immunostaining of the dorsal root entry zone from P60 conditional heterozygote (cHet) and conditional knockout (cKO) (by <italic>Cnp-Cre</italic>) spinal cords for Kv1.1 channels (green), contactin-associated protein (Caspr) (red), and neurofascin (NFasc) (blue). The node at the transition zone is indicated by an arrow and is shared by an oligodendrocyte at the left and a Schwann cell at the right, as illustrated below. The flanking CNS and peripheral nervous system (PNS) paranodes are indicated by arrowheads. Illustration adapted from Figure 1a of <xref ref-type="bibr" rid="bib8">Chang et al., 2016</xref>, with permission. (<bold>B</bold>) Immunostaining of P21 spinal cords for Caspr. cHet and cKO by <italic>Cnp-Cre</italic>. Scale bars, 5 μm (<bold>A, B</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64456-fig3-v1.tif"/><permissions><copyright-statement>© 2016, Springer Nature.</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Springer Nature</copyright-holder><license><license-p>Figure 3A is adapted from Figure 1a of <xref ref-type="bibr" rid="bib8">Chang et al., 2016</xref>, with permission from Springer Nature. Further reproduction of this panel would need permission from the copyright holder.</license-p></license></permissions></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Nodes at the central nervous system–peripheral nervous system (CNS-PNS) transition zone are identified by immunostaining for the PNS paranodal marker ankyrinB (AnkB).</title><p>Immunostaining images of the dorsal root entry zone from the P60 conditional heterozygote (cHet) spinal cord shown in <xref ref-type="fig" rid="fig3">Figure 3A</xref> with Kv1.1 channels (green), contactin-associated protein (Caspr) (red), neurofascin (NFasc) (blue), and AnkB (white). The node at the transition zone is indicated by an arrow, and the flanking CNS and PNS paranodes are indicated by arrowheads. The PNS paranode, but not the CNS paranode, is labeled by AnkB.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64456-fig3-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Fine myelin structures are preserved in the absence of TDP-43</title><p>Schwann cells are highly polarized cells, forming multiple structures to facilitate their functions (<xref ref-type="bibr" rid="bib58">Salzer, 2015</xref>). In view of the potential perturbation in the expression of numerous TDP-43 targets in the cKO Schwann cells, it is likely that other structural changes could be identified, in addition to paranodal junctions.</p><p>Cajal bands are cytoplasmic-network conduits distributed outside compact myelin and are proposed to transport mRNA and proteins from the cell body (<xref ref-type="bibr" rid="bib58">Salzer, 2015</xref>). We examined the nerves for βII spectrin (<xref ref-type="bibr" rid="bib64">Susuki et al., 2011</xref>) and found that Cajal bands are clearly visible in the absence of TDP-43 (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Within compact myelin resides the inner tongue—the innermost cytoplasmic channel of a myelinating Schwann cell. At the interface between the axolemma and the tip of the inner tongue, axoglial interactions create a strand of internodal specialization winding around the axon, called the juxtamesaxon (<xref ref-type="bibr" rid="bib52">Poliak and Peles, 2003</xref>; <xref ref-type="bibr" rid="bib57">Salzer, 2003</xref>). The Kv1 complex is localized at the juxtamesaxon, forming a double-stranded structure (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). In the absence of TDP-43, the juxtamesaxon is formed normally (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Additionally, the lateral cytoplasmic channels of myelinating Schwann cells wrap around the axon and form paranodal loops, which are interconnected by autotypic tight, gap, and adherens junctions (<xref ref-type="bibr" rid="bib57">Salzer, 2003</xref>). By immunostaining for the junctional components (zonula occludens-1 [ZO-1], connexin 32 [Cx32], and E-cadherin [E-cad], respectively), we find that they are all normally enriched at paranodes in the cKO (<xref ref-type="fig" rid="fig4">Figure 4C–E</xref>). Lastly, Schmidt–Lanterman incisures, the cytoplasmic channels that run through the compact myelin and connect the outermost and innermost cytoplasmic compartments of Schwann cells, can be identified by staining for myelin-associated glycoprotein (MAG). Once again, the incisures were normally formed, as observed by the classic funnel-shaped MAG staining in the TDP-43 cKO (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). Taken together, by examining the fine structures found in Schwann cell myelin, our findings suggest that the major effect of ablating TDP-43 in Schwann cells specifically lies in the disruption of paranodal junctions.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>The fine myelin structures are formed normally in the TDP-43-cKO Schwann cells.</title><p>(<bold>A</bold>) Immunostaining of Cajal bands in teased P29 ventral roots with an antibody against βII spectrin. (<bold>B</bold>) Immunostaining of teased P29 ventral roots for ankyrinG (AnkG) (red, node) and Kv1.1 channels (white). Localization of Kv1.1 channels in the juxtamesaxon is indicated by open arrowheads. (<bold>C</bold>) Immunostaining of P28 sciatic nerves for zonula occludens-1 (ZO-1) (magenta) and βIV spectrin (green, node). (<bold>D</bold>) Immunostaining of P28 trigeminal nerves for connexin 32 (Cx32) (magenta) and neurofascin (NFasc) (green). (<bold>E</bold>) Immunostaining of P28 sciatic nerves for E-cadherin (E-cad) (red), myelin-associated glycoprotein (MAG) (blue), and NFasc (green). (<bold>F</bold>) Immunostaining of teased P28 sciatic nerves for MAG (green, incisure) and NFasc (magenta). cHet and cKO by <italic>Dhh-Cre</italic> (<bold>A–F</bold>). Scale bars, 5 μm (<bold>A–F</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64456-fig4-v1.tif"/></fig></sec><sec id="s2-5"><title>NFasc expression requires TDP-43</title><p>How does TDP-43 deletion in Schwann cells induce the specific disruption of paranodal junctions? Among the known essential components, Caspr/Cntn and NF155, only NF155 is expressed by Schwann cells. Therefore, we asked whether the expression or the paranodal clustering of NF155 is impaired in the TDP-43 cKO. Consistent with disrupted expression of NF155, not only is NFasc staining absent from the paranodes in the TDP-43 cKO (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>), but NFasc is also undetectable at the incisures (<xref ref-type="fig" rid="fig4">Figure 4F</xref>). By contrast, although NF155 is not highly clustered at the paranodes in mice lacking Caspr or galactocerebroside/sulfatide, it remains localized at the incisures (<xref ref-type="bibr" rid="bib51">Poliak et al., 2001</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). Taken together, these data strongly suggest that NF155 expression is abolished in the absence of TDP-43.</p><p>NF155 is encoded by <italic>Nfasc,</italic> a highly alternatively spliced gene (<xref ref-type="bibr" rid="bib3">Basak et al., 2007</xref>; <xref ref-type="fig" rid="fig5">Figure 5A</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Alternative splicing generates NFasc proteins with different domain architectures of the extracellular moiety in different cell types (<xref ref-type="bibr" rid="bib13">Davis et al., 1996</xref>; <xref ref-type="bibr" rid="bib12">Davis et al., 1993</xref>; <xref ref-type="bibr" rid="bib67">Tait et al., 2000</xref>). In Schwann cells, <italic>Nfasc</italic> mRNA contains exons 23 and 24 while exons 28–30 are excluded, producing the glial-specific NF155 isoform. In neurons, <italic>Nfasc</italic> transcripts are spliced in the opposite way and are translated into the neuronal-specific NF186 isoform. When the expression of NFasc proteins in sciatic nerves is analyzed by western blotting, we find that NF155 is undetectable in the TDP-43 cKO whereas the level of NF186 is unchanged (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Similarly, the protein expression of Caspr in the cKO nerve also remains unchanged (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Moreover, by immunostaining the nascent nodes and paranodes in P3 sciatic nerves, NFasc is already absent from the cKO paranodes (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Consistently, the mRNA for NF155 is dramatically decreased in the cKO (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). Therefore, our findings strongly suggest that ablating TDP-43 in Schwann cells leads to aberrant NF155 expression and in turn results in the failure of Caspr to cluster at paranodes and form paranodal junctions.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Schwann cell neurofascin (NFasc) expression is abolished in the TDP-43 conditional knockout (cKO).</title><p>(<bold>A</bold>) The schema of mouse <italic>Nfasc</italic> locus showing the region from exon 13 to exon 33. The coding strand of <italic>Nfasc</italic> is located on the reverse strand of chromosome 1, as defined in the GRCm38/mm10 mouse genome assembly, and flipped here for reader convenience. Alternative exons specific to NF155 (exons 23 and 24) or NF186 (exons 28–30) are shown in blue while other alternative exons (exons 18 and 27) are shown in gray. NF140 contains neither exons 23 and 24 nor exons 28–30. The open rectangle denotes the untranslated region, and the solid ones the open reading frame. (<bold>B</bold>) Western blotting of P28 sciatic nerve homogenates probed for NFasc, contactin-associated protein (Caspr), and actin. (<bold>C</bold>) Immunostaining of P3 sciatic nerves for NFasc (green) and ankyrinG (AnkG) (magenta) showing pairs of approaching heminodes (nodes flanked by myelin sheaths only on one side). The paranodes are indicated by arrowheads. Scale bar, 5 μm. (<bold>D</bold>) RT-qPCR analysis of P28–P29 sciatic nerves shows the transcript levels relative to those of the wild-type (WT) after normalized to the internal control <italic>Polr2a</italic>. Exon 3 of <italic>Tardbp</italic> is the floxed exon, and the primer pair for <italic>Tardbp</italic> ex3 detects TDP-43 mRNA transcribed from the unrecombined allele. The primer pair for <italic>Tardbp</italic> exons 4–5 detects the nonfloxed region to confirm mRNA degradation after Cre recombination. Pan-<italic>Nfasc</italic> is detected by primers spanning exons 12–13, NF155 by primers spanning exons 22–23, NF140+ex27 by primers annealing to the junctions of exons 22/25 and exons 27/31, and NF140-ex27 by primers annealing to the junctions of exons 22/25 and exons 26/31. Bars represent mean ± SEM. n = 3 mice per genotype. *p&lt;0.05; **p&lt;0.01; ***p&lt;0.001; ns, p≥0.05; one-sample unpaired two-tailed <italic>t</italic>-tests (WT vs. conditional heterozygote [cHet] and WT vs. cKO). cHet and cKO by <italic>Dhh-Cre</italic> (<bold>B–D</bold>).</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Statistical summary for <xref ref-type="fig" rid="fig5">Figure 5D</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-64456-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64456-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Localization of neurofascin (NFasc) in the Schmidt–Lanterman incisure is not affected in the contactin-associated protein knockout (Caspr KO).</title><p>Immunostaining of P80 sciatic nerves for NFasc. Nodes are indicated by open arrowheads, and paranodes by solid arrowheads. Scale bar, 5 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64456-fig5-figsupp1-v1.tif"/></fig></fig-group><p>In addition to NF155 and NF186, the other major NFasc isoform is NF140 (<xref ref-type="bibr" rid="bib12">Davis et al., 1993</xref>), which contains neither exons 23–24 nor exons 28–30. Unlike NF186, NF140 protein is only faintly detectable in the TDP-43 cKO (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Using the isoform-specific primers in the RT-qPCR analysis, we find that NF140 containing exon 27 (NF140+ex27) remains unchanged, but NF140 without exon 27 (NF140-ex27) dramatically decreases in the TDP-43 cKO (<xref ref-type="fig" rid="fig5">Figure 5D</xref>), suggesting a neuronal source of NF140+ex27 (<xref ref-type="bibr" rid="bib73">Zhang et al., 2015</xref>) and a glial source of NF140-ex27. Together, our observations point to a model where TDP-43 either directly or indirectly regulates the expression of NFasc in Schwann cells, which in turn interacts with Caspr/Cntn on the axolemma and assembles the paranodal junctions.</p></sec><sec id="s2-6"><title>TDP-43 directly regulates NFasc expression by repressing the inclusion of a cryptic exon</title><p>To investigate how TDP-43 regulates <italic>Nfasc</italic> expression, RNA-seq was performed using sciatic nerves isolated from the WT and cKO mice (by <italic>Cnp-Cre</italic>). Intriguingly, when the sequencing reads are aligned to the <italic>Nfasc</italic> locus and analyzed, we find reads mapped to introns 17 and 18 of <italic>Nfasc</italic>. Because intron 17 contains a UG-rich sequence, a known consensus RNA-binding motif for TDP-43 (<xref ref-type="bibr" rid="bib53">Polymenidou et al., 2011</xref>; <xref ref-type="bibr" rid="bib69">Tollervey et al., 2011</xref>; <xref ref-type="fig" rid="fig6">Figure 6A, B</xref>), we data-mined the previously published cross-linking immunoprecipitation and high-throughput sequencing (CLIP-seq) data on TDP-43-binding transcripts in mouse brains (<xref ref-type="bibr" rid="bib53">Polymenidou et al., 2011</xref>) and identify a single cluster of pre-mRNA binding peaks on <italic>Nfasc</italic> located at intron 17 (upper panel of <xref ref-type="fig" rid="fig6">Figure 6A</xref>). Further analysis reveals a 104-bp-long cassette exon in the cKO with a well-defined splice acceptor and splice donor, just upstream to the TDP-43-binding peaks (<xref ref-type="fig" rid="fig6">Figure 6B</xref>), characteristic of TDP-43-repressed cryptic exons (<xref ref-type="bibr" rid="bib37">Ling et al., 2015</xref>). We term this region as cryptic exon 1 (CE1). Quantitative splice junction analyses using the percent spliced in index (PSI) reveal a near complete utilization of the cryptic exon splice acceptor (93.1%) in the cKO sciatic nerves compared with 25.3% in the WT nerves (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). By contrast, the usage of this cryptic splice acceptor is less dramatic (43.9%) in the spinal cords from the same TDP-43-cKO mice (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Cryptic exon located upstream of TDP-43-binding sites on <italic>Nfasc</italic> mRNA is highly expressed in the TDP-43 conditional knockout (cKO).</title><p>(<bold>A</bold>) TDP-43 binds to <italic>Nfasc</italic> mRNA as seen from the TDP-43 mRNA binding CLIP-seq data from mouse brains, which shows binding peaks between exons 17 and 18 of <italic>Nfasc</italic> (upper panel). The exon color code in the upper panel follows that in <xref ref-type="fig" rid="fig5">Figure 5A</xref>; the bent arrows denote the two alternative transcription start sites from exons 1a and 1b (see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> for detail). The lower panel is a zoom into this region of interest, with tracks of wild-type (WT) and TDP-43-cKO sciatic nerve RNA-seq read coverage and Sashimi plots to visualize major junction-spanning reads. The arc width is proportionate to the number of reads spanning the junction, which is labeled below each arc. There is a very large proportion of reads spanning from E17 to a new cryptic exonic region, upstream to the TDP-43-binding sites, in the cKO compared to the WT. (<bold>B</bold>) The RNA sequence transcribed from the cryptic exon (CE1) is given in purple. CE1 contains a stop codon in the open reading frame (ORF), well-defined splice acceptor and donor sites, and a downstream UG-rich TDP-43-binding region, characteristic of TDP-43 cryptic exons. (<bold>C</bold>) RT-PCR for <italic>Nfasc</italic> spliceforms using sciatic nerves and spinal cords isolated from P21 mice. Schematic of <italic>Nfasc</italic> spliceforms shows exon usage: E17–CE1–E19–E20 (i), E17–E18–E19–E20 (ii), and E17–E19–E20 (iii). The bands were excised and sequenced. Chromatograms covering the exon–exon junctions are shown at the left. Conditional heterozygote (cHet) and cKO by <italic>Cnp-Cre</italic>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64456-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>The identified cryptic exon is more highly expressed in sciatic nerves than in spinal cords and is spliced into &gt;90% of <italic>Nfasc</italic> transcripts in the TDP-43-cKO sciatic nerves.</title><p>(<bold>A</bold>) The Sashimi plot derived from the RNA-seq data of sciatic nerves (SCN) and spinal cords (SPC) is shown for <italic>Nfasc</italic> E17–E20. The arc width is proportionate to the number of reads spanning the junction. The Sashimi plot of the SCN RNA-seq data is the same as the one shown in <xref ref-type="fig" rid="fig6">Figure 6A</xref> and is included here for comparison with the SPC data. (<bold>B</bold>) The percent spliced in index (PSI) values of exon–exon junctions of interest. (<bold>C</bold>) Reads from E17 are predominantly spliced to E19 in wild-type (WT) SCN, and this shifts to &gt;90% of reads from E17 spliced to the cryptic exon CE1/2/3 in the TDP-43-cKO SCN. The spliced exon population is tissue-specific. E18 is expressed at a higher proportion in SPC compared to the negligible expression in SCN. The cryptic exon is incorporated into a small proportion of <italic>Nfasc</italic> transcripts in the WT SCN, but is nominally expressed in the WT SPC. Cryptic exon usage is increased in the conditional knockout (cKO) to different extent in SCN and SPC.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64456-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>TDP-43-cKO RNA-seq reads align to novel exonic region upstream of TDP-43-binding regions in <italic>Nfasc</italic>.</title><p>Plotted in the region of interest around the TDP-43-binding region of <italic>Nfasc</italic>, extending from E17 to E20, are the CLIP-seq reads of TDP-43 binding in adult wild-type (WT) mouse brains (red), and RNA-seq data from WT (black) and TDP-43-cKO (blue) sciatic nerves. Read coverage and genomic alignment of the reads are shown, along with annotated exons and novel cryptic exons. The RNA-seq reads spanning exon–exon junctions are connected by gray lines. Reads spanning the junction between E17 and CE1/2/3 or between CE1 and E19 are increased in the TDP-43 conditional knockout (cKO), and the reads spanning the junction of E17 and E19 are dramatically decreased, suggesting that TDP-43 binding to <italic>Nfasc</italic> pre-mRNA excludes the cryptic exon from the resulting mature transcripts.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64456-fig6-figsupp2-v1.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>The identified candidate cryptic exons contain a premature stop codon in the open reading frame (ORF).</title><p>(<bold>A</bold>) A diagram showing the known alternative splicing in the <italic>Nfasc</italic> E17–E20 region and the identified cryptic exon usage. (<bold>B</bold>) Chromosome location and length of E17–E20 and potential cryptic exons. (<bold>C</bold>) The sequence of the cryptic exons around the 3′ and 5′ splice sites. All three potential cryptic exons have the same start site, well-defined splice donor and acceptor sites, and a premature stop codon in the ORF.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64456-fig6-figsupp3-v1.tif"/></fig></fig-group><p>More critically, this newly identified cryptic exon region contains a premature stop codon when spliced with the upstream constitutive exon 17 (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). A premature stop codon is the trigger for nonsense-mediated decay (NMD) (<xref ref-type="bibr" rid="bib30">Karousis and Mühlemann, 2019</xref>), thereby providing the mechanistic explanation to the dramatic reduction of <italic>Nfasc</italic> transcripts and the absence of NFasc protein in the TDP-43-deleted Schwann cells (<xref ref-type="fig" rid="fig4">Figure 4F</xref>, <xref ref-type="fig" rid="fig5">Figure 5</xref>). A discrete band representing a potential truncated NFasc protein (with calculated molecular weight of 69 kDa before glycosylation, caused by the premature stop codon) is undetectable in the cKO by western blotting (<xref ref-type="fig" rid="fig5">Figure 5B</xref>), suggesting that the remaining 20% transcripts could be en route for degradation. Additionally, there are many less representative splice junction reads (&lt;5 reads per species) in the region between CE1 and exon 19 (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>), suggesting weaker splice donor usage downstream of CE1. These reads are also increased upon TDP-43 deletion (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, <xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>), and we collectively term these cryptic exon extensions CE2 and CE3 (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplements 1</xref>–<xref ref-type="fig" rid="fig6s3">3</xref>). Regardless of the usage of CE1, CE2, or CE3, the premature stop codon is present in all these transcripts and thus render them substrates for NMD (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3C</xref>).</p><p>To further confirm the presence of this cryptic exon in <italic>Nfasc</italic>, RT-PCR was performed. The predominant <italic>Nfasc</italic> isoform uses exons 17 and 19 and excludes exon 18 in the WT and cHet mice (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). Consistent with the bioinformatic analysis, the predominant <italic>Nfasc</italic> isoform uses CE1 in the cKO sciatic nerves (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). The precise splice junctions are confirmed by Sanger sequencing of the PCR products (<xref ref-type="fig" rid="fig6">Figure 6Ci-iii</xref>). By contrast, the utilization of CE1 is not observed in the majority of <italic>Nfasc</italic> transcripts in the spinal cords from the same TDP-43-cKO mice, and the CE1-containing PCR product is only faintly detected. Taken together, the data indicate an increased usage of the cryptic exon in <italic>Nfasc</italic> upon the loss of TDP-43 in the myelinating glia, where TDP-43 is required for proper splicing of the vast majority of <italic>Nfasc</italic> transcripts in Schwann cells, but not oligodendrocytes.</p></sec><sec id="s2-7"><title>TDP-43 is required for maintaining paranodal junctions in adult mice</title><p>Gene expression profiles change dramatically when Schwann cells transition from actively myelinating to the mature state (<xref ref-type="bibr" rid="bib45">Patzig et al., 2011</xref>; <xref ref-type="bibr" rid="bib61">Siems et al., 2020</xref>). Therefore, whether TDP-43 continues to control NFasc expression in mature Schwann cells after myelination needs to be addressed. It is clear from the analysis of the P60 cKO nerves that paranodal junctions are still absent (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D, E</xref>, <xref ref-type="fig" rid="fig3">Figure 3A</xref>), suggesting a lack of compensatory factors in the mature state that may bypass the need for TDP-43. To determine if loss of TDP-43 in mature Schwann cells results in termination of NFasc expression and then disassembly of paranodal junctions, we combined <italic>Tardbp<sup>fl/fl</sup></italic> with <italic>Mpz-CreERT2</italic> (<xref ref-type="bibr" rid="bib35">Leone et al., 2003</xref>) (TDP-43 icKO) to conditionally induce deletion of TDP-43 in adulthood (~40–60% TDP-43 recombination efficiency in Krox20<sup>+</sup> Schwann cells). At 3 months post-tamoxifen injection, NFasc is absent from a similar proportion of Schmidt–Lanterman incisures in the sciatic nerves and ventral roots (<xref ref-type="fig" rid="fig7">Figure 7A</xref>, <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>). RT-PCR analysis of the sciatic nerves reveals a dramatic increase in the CE1 usage of <italic>Nfasc</italic> transcripts (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). These observations suggest that TDP-43 continues to play an essential role in regulating NFasc expression by repressing the CE inclusion even in the mature state.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Paranodal junctions are disrupted when TDP-43 is deleted in adult Schwann cells.</title><p>(<bold>A</bold>) Immunostaining of adult sciatic nerves at 3 months after injection of tamoxifen (tam) or corn oil alone (oil) for E-cadherin (E-cad) (incisures) and neurofascin (NFasc). Scale bar, 5 μm. (<bold>B</bold>) RT-PCR for <italic>Nfasc</italic> spliceforms using sciatic nerves at 3 months after tamoxifen administration. +RT, reactions with reverse transcriptase; −RT, reactions without reverse transcriptase. (<bold>C</bold>) Immunostaining of adult sciatic nerves at 5 months after injection of tamoxifen (tam) or corn oil alone (oil) for contactin-associated protein (Caspr) (green), NFasc (blue), and Kv1.1 channel (red). Scale bar, 5 μm. (<bold>D</bold>) The sciatic nerve sections were immunostained for Krox20 and TDP-43 and quantified for the percentage of Krox20-positive nuclei that are TDP-43-negative. Immunostaining for Caspr and Kv1.1 was quantified for the percentage of Kv1.1-positive paranodes/juxtaparanodes that exhibit paranodal junction disruption defined as paranodal invasion of Kv1.1 and/or fragmented/shortened Caspr clusters. n represents the number of paranodes or nuclei analyzed for each mouse.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64456-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Neurofascin (NFasc) turns over faster at the incisures than at the paranodal junctions.</title><p>(<bold>A</bold>) Immunostaining of teased ventral roots from the TDP-43-icKO mice at 3 months after tamoxifen injection for NFasc (magenta), TDP-43 (yellow), myelin-associated glycoprotein (MAG) (green), and DAPI (blue). The cell contour of a TDP-43-KO Schwann cell is delineated with dashed lines, and NFasc is absent from its incisure. The incisures are indicated by arrows. (<bold>B</bold>) Immunostaining of teased ventral roots from the TDP-43-icKO mice at 3 months after tamoxifen injection for NFasc (red) and MAG (cyan). NFasc is absent from the incisure of the bottom Schwann cell but is still enriched at its paranode. The incisures are indicated by arrows, the paranode by a solid arrowhead, and the node by an open arrowhead. Scale bars, 5 μm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64456-fig7-figsupp1-v1.tif"/></fig></fig-group><p>NFasc is notorious for its stability in the molecular domains where it is involved and requires a long time for protein turnover after adult or juvenile NFasc deletion (8–16 weeks at nodes; ≥8 weeks at paranodes) (<xref ref-type="bibr" rid="bib14">Desmazieres et al., 2014</xref>; <xref ref-type="bibr" rid="bib49">Pillai et al., 2009</xref>; <xref ref-type="bibr" rid="bib75">Zonta et al., 2011</xref>). While NFasc protein is absent from the TDP-43-icKO incisures with residual NFasc still detected at paranodes to different extent, the paranodal diffusion barrier is compromised (<xref ref-type="fig" rid="fig7">Figure 7C</xref>, <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B</xref>). This ranges from paranodal invasion of Kv1.1 to fragmentation or shortening of Caspr clusters (<xref ref-type="fig" rid="fig7">Figure 7C</xref>), and is consistent with the ongoing disassembly of paranodal junctions, similar to when <italic>Nfasc</italic> is ablated from mature Schwann cells (<xref ref-type="bibr" rid="bib49">Pillai et al., 2009</xref>). The proportion of paranodal junctions that are disrupted at 5 months post-tamoxifen injection is similar to the icKO recombination efficiency (<xref ref-type="fig" rid="fig7">Figure 7D</xref>), suggesting that paranodal disruption is prevalent among the mature Schwann cells lacking TDP-43. Altogether, our findings strongly suggest that TDP-43 in mature Schwann cells continues to repress the CE inclusion and supply NFasc for maintaining paranodal junctions.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>TDP-43 is a ubiquitously expressed RNA/DNA-binding protein that covers one third of the transcriptome as potential targets of regulation (<xref ref-type="bibr" rid="bib15">Ederle and Dormann, 2017</xref>; <xref ref-type="bibr" rid="bib36">Ling et al., 2013</xref>). Consistent with its broad expression, emerging evidence indicates that the physiological and pathological roles for TDP-43 are no longer limited to neurons, but that TDP-43 is essential for normal function in glia (<xref ref-type="bibr" rid="bib44">Paolicelli et al., 2017</xref>; <xref ref-type="bibr" rid="bib48">Peng et al., 2020</xref>; <xref ref-type="bibr" rid="bib70">Velebit et al., 2020</xref>; <xref ref-type="bibr" rid="bib71">Wang et al., 2018</xref>). Additionally, the PNS has long been overlooked, though cell-autonomous roles for TDP-43 in peripheral cells have been implicated (<xref ref-type="bibr" rid="bib25">Gentile et al., 2019</xref>). In this study, we demonstrate for the first time an essential role for TDP-43 in Schwann cells to facilitate rapid nerve conduction. We find that loss of TDP-43 in Schwann cells does not alter the structure of compact myelin, but instead the paranodal junction—the attachment site of myelin to the axon—is specifically disrupted, resulting in a 50% delay in nerve conduction velocity and functional motor deficits. Furthermore, we identify a previously unknown cryptic exon in the <italic>Nfasc</italic> gene, which overlaps with TDP-43-binding sites. Schwann cell NFasc protein is known to be essential for paranodal junction assembly and maintenance (<xref ref-type="bibr" rid="bib49">Pillai et al., 2009</xref>; <xref ref-type="bibr" rid="bib74">Zonta et al., 2008</xref>). We uncover the almost exclusive inclusion of this cryptic exon in the TDP-43-cKO Schwann cells, which introduces a premature stop codon and completely abolishes NFasc protein production, therefore, remarkably phenocopying NFasc cKO and icKO in Schwann cells (<xref ref-type="bibr" rid="bib49">Pillai et al., 2009</xref>). The possession of a myriad of targets implies that TDP-43 is a pleiotropic gene, and we find that the myelinated axons in the TDP-43 cKO tend to have smaller diameters that may also contribute to the conduction delay (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B</xref>). However, from various studies, the absence of paranodal junctions in mice lacking Caspr or Schwann cell NFasc results in ~40–50% peripheral nerve conduction delay (<xref ref-type="bibr" rid="bib5">Bhat et al., 2001</xref>; <xref ref-type="bibr" rid="bib49">Pillai et al., 2009</xref>; <xref ref-type="bibr" rid="bib65">Susuki et al., 2013</xref>), and we observe an average 52% delay in the TDP-43 cKO, suggesting that the absence of Schwann cell NFasc and paranodal junctions is the main contributor to the conduction delay in the TDP-43 cKO. All in all, our findings point to an absolute requirement of Schwann cell TDP-43 for NFasc expression and paranodal junction assembly/maintenance, and provide a framework for a mechanism where TDP-43 alters nerve conduction velocity by exerting its function in PNS myelin-forming glia to regulate neuron–glial interactions.</p><p>Schwann cell differentiation and myelination are controlled under a network of interacting transcription factors and signaling pathways (<xref ref-type="bibr" rid="bib39">Monk et al., 2015</xref>; <xref ref-type="bibr" rid="bib63">Stolt and Wegner, 2016</xref>). <italic>Nfasc</italic> and <italic>Gldn</italic> mRNA expression in Schwann cells coincides with the onset of myelination (<xref ref-type="bibr" rid="bib3">Basak et al., 2007</xref>), suggesting that the transcriptional control for myelination also participates in orchestrating the formation of nodal and paranodal molecular domains during myelination. Nevertheless, the insufficiency of transcriptional regulation alone for controlling the precise timing of node assembly has recently been revealed for Gldn, whose node-inducing activity in premyelinating ensheathing Schwann cells is inhibited by Tolloid-like proteinases (<xref ref-type="bibr" rid="bib19">Eshed-Eisenbach et al., 2020</xref>). Our identification of the novel cryptic exon residing in intron 17 of <italic>Nfasc</italic> may provide a fine-tuning mechanism governed by TDP-43, especially as the expression of TDP-43 is found to be highly regulated during development (<xref ref-type="bibr" rid="bib59">Sephton et al., 2010</xref>) and may differ between cell types. Alternatively, TDP-43 may just play an all-or-none role in maintaining the intron integrity for <italic>Nfasc</italic> intron 17 to ensure NFasc expression. Future studies will determine whether and how the expression timing and paranodal stoichiometry of NFasc are regulated by TDP-43 and will provide further insight into the functional role of TDP-43 in the timely assembly and proper maintenance of paranodal junctions.</p><p>TDP-43 and NFasc are expressed by both Schwann cells and oligodendrocytes. Therefore, it is surprising to find that TDP-43 is required for NFasc expression and paranodal junction assembly exclusively in Schwann cells and not oligodendrocytes. Through our RNA-seq and splicing analyses, we also identify an increased usage of this <italic>Nfasc</italic> cryptic exon in the TDP-43-cKO spinal cords, although this usage is not increased to the same extent as in sciatic nerves. This suggests that TDP-43 actually performs in a similar manner on <italic>Nfasc</italic> expression by repressing this cryptic exon in both PNS and CNS myelinating glia. Conceivably, the difference in the extent of regulation in Schwann cells and oligodendrocytes may result from the different compositions of various RNA-binding proteins that regulate pre-mRNA splicing in different cell types (<xref ref-type="bibr" rid="bib24">Fu and Ares, 2014</xref>). Future studies will identify the RNA-binding proteins in oligodendrocytes that may repress the <italic>Nfasc</italic> cryptic exon in the absence of TDP-43. Furthermore, neuronal NFasc (NF186) is highly enriched at the axon initial segments and nodes and is required for maintaining the high density of Nav channels therein (<xref ref-type="bibr" rid="bib1">Amor et al., 2017</xref>; <xref ref-type="bibr" rid="bib14">Desmazieres et al., 2014</xref>; <xref ref-type="bibr" rid="bib75">Zonta et al., 2011</xref>). Ablation of neuronal NFasc drastically impairs the spontaneous firing of Purkinje neurons and delays peripheral nerve conduction. Given that this newly identified <italic>Nfasc</italic> cryptic exon is located immediately downstream of a constitutive exon shared by all NFasc isoforms, follow-up studies should investigate to what extent the expression level of neuronal NFasc is affected with the loss of function for TDP-43. Although not discussed in a previous study where TDP-43 is overexpressed under the Thy1.2 promoter to induce its aggregation in neurons, <italic>Nfasc</italic> is among the top-21 downregulated genes (<xref ref-type="bibr" rid="bib60">Shan et al., 2010</xref>). Retrospectively, the direct regulation mechanism we uncover here may be generalizable to the physiology of neurons as well.</p><p>TDP-43 aggregates have been described in both neurons and glia in the CNS for over a decade (<xref ref-type="bibr" rid="bib2">Arai et al., 2006</xref>; <xref ref-type="bibr" rid="bib42">Neumann et al., 2006</xref>). It was not until recently that the pathological TDP-43 aggregates were discovered in Schwann cells in an ALS patient (<xref ref-type="bibr" rid="bib40">Nakamura-Shindo et al., 2020</xref>). Our findings reveal that Schwann cell TDP-43 is essential for the formation and maintenance of paranodal junctions, and the cKO mice display motor deficits when challenged on the rotarod, suggesting that optimal nerve conduction in the PNS provided by Schwann cell TDP-43 and paranodal junctions is essential for motor coordination. Some distinct potential TDP-43-binding sites on human <italic>NFASC</italic> pre-mRNA could be identified using the human CLIP-seq data set (<xref ref-type="bibr" rid="bib69">Tollervey et al., 2011</xref>) (data not shown). Therefore, follow-up studies are necessary to provide a comprehensive view on whether TDP-43 binds to <italic>NFASC</italic> transcripts and regulates <italic>NFASC</italic> expression in human Schwann cells, and to determine the prevalence of Schwann cell TDP-43 aggregates in patients and the functional consequence. Our findings are the first to demonstrate a functional role for TDP-43 in axon–glial interactions in the PNS and provide a framework and mechanism for how Schwann cell-autonomous dysfunction in nerve conduction is directly caused by TDP-43 loss of function.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or <break/>resource</th><th>Designation</th><th>Source or <break/>reference</th><th>Identifiers</th><th>Additional <break/>information</th></tr></thead><tbody><tr><td>Genetic reagent (<italic>Mus musculus</italic>)</td><td><italic>Tardbp<sup>fl/fl</sup></italic></td><td>Jackson Laboratory</td><td>Stock #: 017591; MGI:4834273</td><td/></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td><italic>Dhh-Cre</italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/12782656">12782656</ext-link></td><td>MGI:4359600</td><td>Dr. Dies Meijer</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td><italic>Mpz-Cre</italic> <break/>(<italic>P0-Cre</italic>)</td><td>Jackson Laboratory</td><td>Stock #: 017927; MGI:2450448</td><td/></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td><italic>Cnp-Cre</italic></td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/12590258">12590258</ext-link></td><td>MGI:3051635</td><td>Dr. Klaus-Armin Nave</td></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td><italic>Cntnap1<sup>-/-</sup></italic> <break/>(Caspr KO)</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/14676309">14676309</ext-link></td><td>MGI:3026869</td><td/></tr><tr><td>Genetic reagent (<italic>M. musculus</italic>)</td><td><italic>Mpz-CreERT2</italic> <break/>(<italic>P0-CreERT2</italic>)</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/12727441">12727441</ext-link></td><td>MGI:2663097</td><td>Drs. Ueli Suter and Gabriel Corfas</td></tr><tr><td>Antibody</td><td>Anti-actin (mouse monoclonal C4)</td><td>MilliporeSigma</td><td>Cat #: MAB1501R; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2223041">AB_2223041</ext-link></td><td>(1:5000)</td></tr><tr><td>Antibody</td><td>Anti-AnkB (mouse monoclonal N105/17)</td><td>UC Davis/NIH NeuroMab Facility</td><td>Clone: N105/17; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10674432">AB_10674432</ext-link></td><td>(1:10)</td></tr><tr><td>Antibody</td><td>Anti-AnkG (mouse monoclonal N106/36)</td><td>UC Davis/NIH NeuroMab Facility</td><td>Clone: N106/36; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10697718">AB_10697718</ext-link></td><td>(1:10)</td></tr><tr><td>Antibody</td><td>Anti-AnkG (mouse monoclonal N106/65)</td><td>UC Davis/NIH NeuroMab Facility</td><td>Clone: N106/65; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10673449">AB_10673449</ext-link></td><td>(1:10)</td></tr><tr><td>Antibody</td><td>Anti-βII spectrin (mouse monoclonal 42)</td><td>BD Biosciences</td><td>Cat #: 612562; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_399853">AB_399853</ext-link></td><td>(1:200)</td></tr><tr><td>Antibody</td><td>Anti-βIV spectrin (chicken polyclonal)</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/20980605">20980605</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2827639">AB_2827639</ext-link></td><td>(1:200) <break/>Dr. Matthew N. Rasband</td></tr><tr><td>Antibody</td><td>Anti-βIV spectrin (rabbit polyclonal)</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/15317849">15317849</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2315634">AB_2315634</ext-link></td><td>(1:500) <break/>Dr. Matthew N. Rasband</td></tr><tr><td>Antibody</td><td>Anti-Caspr (mouse monoclonal Mab275)</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/10624965">10624965</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2314218">AB_2314218</ext-link></td><td>(1:200)</td></tr><tr><td>Antibody</td><td>Anti-Caspr (rabbit polyclonal)</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/9118959">9118959</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2314220">AB_2314220</ext-link></td><td>(1:800 staining)</td></tr><tr><td>Antibody</td><td>Anti-Caspr (rabbit polyclonal)</td><td>Abcam</td><td>Cat#: ab34151; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_869934">AB_869934</ext-link></td><td>(1:1000 blotting)</td></tr><tr><td>Antibody</td><td>Anti-Caspr2 (rabbit polyclonal)</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/10624965">10624965</ext-link></td><td/><td>(1:500)</td></tr><tr><td>Antibody</td><td>Anti-Cntn (goat polyclonal)</td><td>R&amp;D Systems</td><td>Cat #: AF904-SP; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2292070">AB_2292070</ext-link></td><td>(1:500)</td></tr><tr><td>Antibody</td><td>Anti-Cx32 (mouse monoclonal 5F9A9)</td><td>Thermo Fisher Scientific</td><td>Cat #: 35-8900; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2533228">AB_2533228</ext-link></td><td>(1:200)</td></tr><tr><td>Antibody</td><td>Anti-E-cadherin (mouse monoclonal 36)</td><td>BD Biosciences</td><td>Cat #: 610181; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_397580">AB_397580</ext-link></td><td>(1:200)</td></tr><tr><td>Antibody</td><td>Anti-Gldn (mouse monoclonal Mab94)</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/16039564">16039564</ext-link></td><td/><td>(1:200)</td></tr><tr><td>Antibody</td><td>Anti-Gldn (rabbit polyclonal)</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/17485493">17485493</ext-link></td><td/><td>(1:500)</td></tr><tr><td>Antibody</td><td>Anti-Krox20 (rabbit polyclonal)</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/15282162">15282162</ext-link></td><td/><td>(1:800) <break/>Dr. Dies Meijer</td></tr><tr><td>Antibody</td><td>Anti-Kv1.1 (mouse monoclonal K20/78)</td><td>UC Davis/NIH NeuroMab Facility</td><td>Clone: K20/78; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10672854">AB_10672854</ext-link></td><td>(1:10)</td></tr><tr><td>Antibody</td><td>Anti-Kv1.2 (rabbit polyclonal)</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/7623158">7623158</ext-link></td><td/><td>(1:500) <break/>Dr. Matthew N. Rasband</td></tr><tr><td>Antibody</td><td>Anti-MAG (mouse monoclonal 513)</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/2444603">2444603</ext-link></td><td/><td>(1:500) <break/>Dr. Marie T. Filbin</td></tr><tr><td>Antibody</td><td>Anti-NFasc (chicken polyclonal)</td><td>R&amp;D Systems</td><td>Cat #: AF3235; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10890736">AB_10890736</ext-link></td><td>(1:200 staining) <break/>(1:500 blotting)</td></tr><tr><td>Antibody</td><td>Anti-panNav (mouse monoclonal K58/35)</td><td>MilliporeSigma</td><td>Cat #: S8809; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_477552">AB_477552</ext-link></td><td>(1:200)</td></tr><tr><td>Antibody</td><td>Anti-PDGFRα (rabbit polyclonal)</td><td>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/8714519">8714519</ext-link></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2315173">AB_2315173</ext-link></td><td>(1:2000) <break/>Dr. William B. Stallcup</td></tr><tr><td>Antibody</td><td>Anti-Sox10 (goat polyclonal)</td><td>R&amp;D Systems</td><td>Cat #: AF2864; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_442208">AB_442208</ext-link></td><td>(1:200)</td></tr><tr><td>Antibody</td><td>Anti-TDP-43 (mouse monoclonal 3H8)</td><td>EnCor Biotechnology</td><td>Cat #: MCA-3H8; <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2572387">AB_2572387</ext-link></td><td>(1:800)</td></tr><tr><td>Antibody</td><td>Anti-TDP-43 (rabbit polyclonal)</td><td>Proteintech</td><td>Cat #: 10782-2-AP; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_615042">AB_615042</ext-link></td><td>(1:500)</td></tr><tr><td>Antibody</td><td>Anti-ZO-1 (mouse monoclonal 1A12)</td><td>Thermo Fisher Scientific</td><td>Cat #: 33-9100; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2533147">AB_2533147</ext-link></td><td>(1:200)</td></tr><tr><td>Antibody</td><td>Anti-chicken AMCA (goat polyclonal)</td><td>Jackson ImmunoResearch</td><td>Cat#: 103-155-155; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2337385">AB_2337385</ext-link></td><td>(1:200)</td></tr><tr><td>Antibody</td><td>Anti-chicken AlexaFluor 594 (goat polyclonal)</td><td>Thermo Fisher Scientific</td><td>Cat#: A-11042; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534099">AB_2534099</ext-link></td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>Anti-chicken DyLight 680 (goat polyclonal)</td><td>Rockland</td><td>Cat #: 603-144-126; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1057473">AB_1057473</ext-link></td><td>(1:10,000)</td></tr><tr><td>Antibody</td><td>Anti-goat AlexaFluor 594 (donkey polyclonal)</td><td>Thermo Fisher Scientific</td><td>Cat#: A-11058; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534105">AB_2534105</ext-link></td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>Anti-mouse IRDye 800CW (goat polyclonal)</td><td>LI-COR Biotechnology</td><td>Cat #: 925-32210; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2687825">AB_2687825</ext-link></td><td>(1:10,000)</td></tr><tr><td>Antibody</td><td>Anti-mouse IgG1 AlexaFluor 488 (goat polyclonal)</td><td>Thermo Fisher Scientific</td><td>Cat#: A-21121; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535764">AB_2535764</ext-link></td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>Anti-mouse IgG1 AlexaFluor 594 (goat polyclonal)</td><td>Thermo Fisher Scientific</td><td>Cat#: A-21125; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535767">AB_2535767</ext-link></td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>Anti-mouse IgG1 AlexaFluor 647 (goat polyclonal)</td><td>Thermo Fisher Scientific</td><td>Cat#: A-21240; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535809">AB_2535809</ext-link></td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>Anti-mouse IgG2a AlexaFluor 488 (goat polyclonal)</td><td>Thermo Fisher Scientific</td><td>Cat#: A-21131; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535771">AB_2535771</ext-link></td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>Anti-mouse IgG2a AlexaFluor 594 (goat polyclonal)</td><td>Jackson ImmunoResearch</td><td>Cat#: 115-585-206; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2338886">AB_2338886</ext-link></td><td>(1:800)</td></tr><tr><td>Antibody</td><td>anti-mouse IgG2a AlexaFluor 647 (goat polyclonal)</td><td>Thermo Fisher Scientific</td><td>Cat#: A-21241; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535810">AB_2535810</ext-link></td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>Anti-mouse IgG2b AlexaFluor 594 (goat polyclonal)</td><td>Thermo Fisher Scientific</td><td>Cat#: A-21145; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535781">AB_2535781</ext-link></td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>Anti-mouse IgG2b AlexaFluor 647 (goat polyclonal)</td><td>Thermo Fisher Scientific</td><td>Cat#: A-21242; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535811">AB_2535811</ext-link></td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>Anti-rabbit AlexaFluor 488 (donkey polyclonal)</td><td>Thermo Fisher Scientific</td><td>Cat#: A-21206; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535792">AB_2535792</ext-link></td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>Anti-rabbit AlexaFluor 488 (goat polyclonal)</td><td>Thermo Fisher Scientific</td><td>Cat#: A-11034; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2576217">AB_2576217</ext-link></td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>Anti-rabbit AlexaFluor 594 (goat polyclonal)</td><td>Thermo Fisher Scientific</td><td>Cat#: A-11037; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_253409">AB_253409</ext-link></td><td>(1:1000)</td></tr><tr><td>Antibody</td><td>Anti-rabbit IRDye 800CW (goat polyclonal)</td><td>LI-COR Biotechnology</td><td>Cat #: 925-32211; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2651127">AB_2651127</ext-link></td><td>(1:10,000)</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice</title><p>Construction of the mouse lines was described previously: <italic>Tardbp<sup>fl/fl</sup></italic> (<xref ref-type="bibr" rid="bib9">Chiang et al., 2010</xref>) (JAX 017591); <italic>Dhh-Cre</italic> (<xref ref-type="bibr" rid="bib29">Jaegle et al., 2003</xref>); <italic>Mpz-Cre</italic> (<italic>P0-Cre</italic>) (<xref ref-type="bibr" rid="bib21">Feltri et al., 1999</xref>) (JAX 017927); <italic>Cnp-Cre</italic> (<xref ref-type="bibr" rid="bib34">Lappe-Siefke et al., 2003</xref>); <italic>Cntnap1<sup>-/-</sup></italic> (Caspr KO) (<xref ref-type="bibr" rid="bib26">Gollan et al., 2003</xref>); <italic>Mpz-CreERT2</italic> (<italic>P0-CreERT2</italic>) (<xref ref-type="bibr" rid="bib35">Leone et al., 2003</xref>). All experiments involving mice were performed in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals or the Association for Assessment and Accreditation of Laboratory Animal Care guidelines for animal use and were preapproved by the Institutional Animal Care and Use Committees at the University of California, San Francisco (protocol number: AN180003), National University of Singapore (protocol numbers: BR17-0928 and R17-0634), and Wright State University (Animal Use Protocol # 1113). The mice were housed in barrier facilities under a 12 hr light/dark cycle with free access to food and water. Male and female mice were randomly allocated to the experimental groups according to their age and genotypes. For the icKO experiments, tamoxifen was dissolved in corn oil at 20 mg/ml by shaking at 37°C overnight, and 0.1–0.14 ml (100 mg tamoxifen/kg body weight) was administered intraperitoneally once per day for five consecutive days.</p></sec><sec id="s4-2"><title>Antibodies</title><p>The following primary antibodies were used: mouse anti-actin (MilliporeSigma, C4), mouse anti-AnkB (UC Davis/NIH NeuroMab Facility, N105/17), mouse anti-AnkG (NeuroMab, N106/36), mouse anti-AnkG (NeuroMab, N106/65), mouse anti-βII spectrin (BD Biosciences, 42), chicken anti-βIV spectrin (a gift from Dr. Matthew N. Rasband), rabbit anti-βIV spectrin (a gift from Dr. Matthew N. Rasband, Baylor College of Medicine), mouse anti-Caspr (Mab275) (<xref ref-type="bibr" rid="bib50">Poliak et al., 1999</xref>), rabbit anti-Caspr (<xref ref-type="bibr" rid="bib47">Peles et al., 1997</xref>), rabbit anti-Caspr (Abcam ab34151), rabbit anti-Caspr2 (<xref ref-type="bibr" rid="bib50">Poliak et al., 1999</xref>), goat anti-Cntn (R&amp;D Systems, AF904), mouse anti-Cx32 (Thermo Fisher Scientific, 5F9A9), mouse anti-E-cadherin (BD Biosciences, 36), mouse anti-Gldn (Mab94) (<xref ref-type="bibr" rid="bib17">Eshed et al., 2005</xref>), rabbit anti-Gldn (<xref ref-type="bibr" rid="bib18">Eshed et al., 2007</xref>), rabbit anti-Krox20 (a gift from Dr. Dies Meijer, University of Edinburgh), mouse anti-Kv1.1 channel (NeuroMab, K20/78), rabbit anti-Kv1.2 channel (a gift from Dr. Matthew N. Rasband), mouse anti-MAG (513) (a gift from Dr. Marie T. Filbin, The City University of New York), chicken anti-NFasc (R&amp;D Systems, AF3235), mouse anti-panNav channels (MilliporeSigma, K58/35), rabbit anti-PDGFRα (a gift from Dr. William B. Stallcup, Sanford Burnham Prebys Medical Discovery Institute), goat anti-Sox10 (R&amp;D Systems, AF2864), mouse anti-TDP-43 (EnCor Biotechnology, 3H8), rabbit anti-TDP-43 (Proteintech, 10782-2-AP), and mouse anti-ZO-1 (Thermo Fisher Scientific, 1A12). The secondary antibodies were purchased from Thermo Fisher Scientific, LI-COR Biotechnology, and Jackson ImmunoResearch Laboratories.</p></sec><sec id="s4-3"><title>Immunostaining</title><p>The sciatic nerves, trigeminal nerves, and spinal cords were either dissected after transcardial perfusion and postfixed as described previously (<xref ref-type="bibr" rid="bib71">Wang et al., 2018</xref>) or freshly dissected and then fixed in 4% (w/v) paraformaldehyde (PFA) in 0.1 M sodium phosphate (PB), pH7.4, for 30 min (nerves) or 1 hr (spinal cords) on ice. Fixed tissues were immersed in 20% (w/v) sucrose in 0.1 M PB at 4°C overnight and embedded in a mixture containing 5% (w/v) sucrose, 25 mM PB, and 75% (v/v) O.C.T. Compound (Sakura Finetek) for cryosectioning. Tissue sections were spread onto gelatin-coated coverslips. Alternatively, fixed nerves or spinal nerve roots were immersed in 150 mM sodium chloride, 10 mM sodium phosphate (PBS), pH 7.2, and teased on gelatin-coated coverslips. The teased nerve fibers were permeabilized in 100% methanol at −20°C for 10 min and rinsed with PBS three times before subjected to the subsequent staining procedure.</p><p>After air dried, the tissues on the coverslips were blocked with 10% (v/v) normal goat or donkey serum, 0.3% (v/v) Triton X-100 in PBS for 30 min, and stained with primary antibodies diluted in the blocking solution at 4°C overnight. After one wash with the blocking solution and two washes with PBS for 5 min each, the tissues were stained with secondary antibodies diluted in the blocking solution at room temperature for 1 hr. After one wash with the blocking solution and two washes with PBS, the coverslips were mounted onto glass slides in Vectashield Vibrance mountant (Vector Laboratories) or ProLong Diamond mountant (Thermo Fisher Scientific).</p></sec><sec id="s4-4"><title>Electrophysiology</title><p>Nerve conduction studies were performed as described previously with modification (<xref ref-type="bibr" rid="bib43">Otani et al., 2017</xref>). In brief, the sciatic nerve and its tibial branch were stimulated by needle electrodes inserted close to the nerve at the ankle and sciatic notch under general anesthesia with 2% (v/v) isoflurane inhalation. Supramaximal stimulations were used, and the evoked compound muscle action potentials were recorded from the plantar muscles through needle electrodes placed transversely over the muscle bellies in the sole of the foot. Motor nerve conduction velocity was calculated by dividing the distance between the ankle and sciatic notch by the difference in latency between the ankle and sciatic notch.</p></sec><sec id="s4-5"><title>Transmission electron microscopy</title><p>After sacrificing the mice, the sciatic nerves were exposed and the lower bodies of the mice were fixed in 4% (w/v) PFA, 2.5% (w/v) glutaraldehyde in 0.1 M sodium cacodylate, 5 mM calcium chloride, pH 7.4 at room temperature overnight, and at 4°C for 2 days. Nerves were dissected and stored in the same fixative at 4°C for at least 2 days. Nerves were then processed as previously described (<xref ref-type="bibr" rid="bib20">Feinberg et al., 2010</xref>) and were examined using an FEI Tecnai T12 transmission electron microscope or Tecnai F20 S/TEM equipped with an XF416 TVIP camera or a US4000 Gatan camera, respectively.</p></sec><sec id="s4-6"><title>Rotarod analysis</title><p>Four-week-old mice were first familiarized with the rotarod (Ugo Basile 47600 V04) at 4 rpm for 5 min. Thirty minutes later, the mice were challenged with accelerating rotarod from 4 to 40 rpm within 5 min for three trials, separated by 30 min. The next day, the mice were tested with the rotation speed increased from 4 rpm to 24 or 32 rpm within 30 s and maintained at 24 or 32 rpm, respectively, for another 60 s. Three trials were performed for each speed, and the mice were allowed to rest for at least 10 min between trials. The time periods for which each mouse remained on the rotarod at each speed were recorded and averaged.</p></sec><sec id="s4-7"><title>Preparation of nerve homogenates for western blotting</title><p>Sciatic nerves were homogenized with sonication in 320 mM sucrose, 5 mM sodium phosphate (pH 7.2), 0.2 mM sodium fluoride, 0.2 mM sodium orthovanadate, 1× cOmplete protease inhibitor cocktail (Roche), and 1 mM phenylmethylsulfonyl fluoride on ice. The protein concentration was determined with the BCA protein assay kit (Thermo Fisher Scientific) using the standard curve derived from a serial dilution of bovine serum albumin; 30 μg of total protein was subjected to western blotting.</p></sec><sec id="s4-8"><title>Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)</title><p>Sciatic nerves were homogenized in the TRIzol reagent (Thermo Fisher Scientific) using a Dounce homogenizer (Wheaton) and incubated at room temperature for 5 min. The homogenate was extracted with chloroform, incubated at room temperature for 3 min, and centrifuged at 12,000×<italic>g</italic> for 15 min at 4°C. The total RNA was purified from the supernatant using the Direct-zol RNA Miniprep kit (Zymo Research) by following the manufacturer’s instruction including the in-column DNase I treatment. 0.5 μg of total RNA (concentration determined by the absorbance at 260 nm) was used in 20 μl of reverse transcription reaction with LunaScript RT SuperMix (New England Biolabs) and its No-RT Control Mix according to the manufacturer’s instruction. The RT and No-RT reactions were then diluted to 1/4× with deionized water, and 2 μl was used for qPCR in 25 μl of reaction containing 0.5 μM primers with Power SYBR Green PCR Master Mix and QuantStudio 3 Real-Time PCR System (Thermo Fisher Scientific). The thermocycling parameters are 95°C for 10 min, and 40 cycles of 95°C for 15 s and 60°C for 1 min, followed by melting curve analysis. The primers used in qPCR are as follows (from 5′ to 3′): <italic>Tardbp</italic> ex3 (forward: <named-content content-type="sequence">GGAGAGGTTCTTATGGTTCAGG</named-content>; reverse: <named-content content-type="sequence">TTCTCAAAGGCTCGTCTGG</named-content>; 187 bp), <italic>Tardbp</italic> ex4-5 (forward: <named-content content-type="sequence">TGGTGTGACTGTAAACTTCCC</named-content>; reverse: <named-content content-type="sequence">CGAAGGCAAAAGCTCTGAATG</named-content>; 181 bp), pan <italic>Nfasc</italic> (forward: <named-content content-type="sequence">CAGTGGATGGTGAATGGAG</named-content>; reverse: <named-content content-type="sequence">GCAGGTAGCCATGTTCATTG</named-content>; 148 bp), NF155 (forward: <named-content content-type="sequence">CCTGTCTACGTTCCCTATGAG</named-content>; reverse: <named-content content-type="sequence">GTTCCACTGAAGGCTGATG</named-content>; 168 bp), NF140+ex27 (forward: <named-content content-type="sequence">GGAGAAGATTTACCCAGTGC</named-content>; reverse: <named-content content-type="sequence">TATTGGTGTAAGCTGCAGTT</named-content>; 334 bp), NF140-ex27 (forward: the same as NF140+ex27; reverse: <named-content content-type="sequence">GGTTATTGGTGTAAGCTTCATTT</named-content>; 322 bp), <italic>G6pdx</italic> (forward: <named-content content-type="sequence">CCTCAACAGCCACATGAATG</named-content>; reverse: <named-content content-type="sequence">GGTTCGACAGTTGATTGGAG</named-content>; 197 bp), and <italic>Polr2a</italic> (forward: <named-content content-type="sequence">CATCAAGAGAGTGCAGTTCG</named-content>; reverse: <named-content content-type="sequence">CCATTAGTCCCCCAAGTTTG</named-content>; 125 bp). <italic>Polr2a</italic> was chosen as the reference gene (<xref ref-type="bibr" rid="bib54">Radonić et al., 2004</xref>), and the standard deviations of the <italic>Polr2a</italic> C<sub>q</sub> values among WT, cHet, and cKO ranged from 0.100 to 0.131. We also tested the expression consistency of <italic>G6pdx</italic> and found that <italic>Polr2a</italic> outcompetes <italic>G6pdx</italic> (the <italic>G6pdx</italic> C<sub>q</sub> standard deviations among WT, cHet ,and cKO were up to 0.183). The efficiency of each primer pair was validated to be between 90% and 110% with six points of threefold or fourfold serial dilutions of P16 mouse sciatic nerve cDNAs or P31 mouse spinal cord cDNAs. The primer specificity was screened on the Ensembl genome browser by using the BLASTN search tool against the cDNA database and genomic sequence, and confirmed by gel electrophoresis and sequencing from both ends of the PCR products. Technical triplicates of the RT reaction and duplicates of the No-RT reaction were performed for each biological replicate, and three biological replicates were analyzed. The relative transcript level was calculated by the ΔΔC<sub>q</sub> method. Comparison of cHet or cKO with WT was carried out by one-sample unpaired two-tailed <italic>t</italic>-tests with the test mean equal to 1.</p></sec><sec id="s4-9"><title>RT-PCR</title><p>Total RNA was extracted from sciatic nerves and spinal cords using the TRIzol reagent according to manufacturer’s instruction. After DNase treatment using RQ1 RNase-Free DNase (Promega), 0.5–1 μg of RNA was reverse transcribed using Maxima First Strand cDNA Synthesis Kit for RT-qPCR (Thermo Fisher Scientific) and subsequently used for PCR. Primers for mouse <italic>Nfasc</italic> gene spanning exons 17 and 20 were (from 5′ to 3′): <named-content content-type="sequence">GCAAAGGCCTACCTCACTGT</named-content> (forward) and <named-content content-type="sequence">CTCGTTGACAGCGATGACTC</named-content> (reverse). Similar results were also obtained by using <named-content content-type="sequence">GACCAGGGCAGTTACACG</named-content> (forward, exon 17) and <named-content content-type="sequence">TCACACTCCTCTCAGCCAG</named-content> (reverse, exon 19). The PCR products were resolved in agarose gel.</p></sec><sec id="s4-10"><title>RNA-seq and cryptic exon analysis</title><p>RNA extracted from the sciatic nerves of 21-day-old <italic>Tardbp<sup>fl/fl</sup></italic>, <italic>Cnp-Cre;Tardbp<sup>fl/+</sup></italic>, and <italic>Cnp-Cre;Tardbp<sup>fl/fl</sup></italic> mice (n = 3 per genotype) were used to prepare RNA-seq libraries using the TruSeq RNA Sample Prep Kit (Illumina). Illumina HiSeq4000 was used for paired-end 151 bp sequencing and yielded 30–40 million reads per sample. This data has been deposited in NCBI's Gene Expression Omnibus (<xref ref-type="bibr" rid="bib16">Edgar et al., 2002</xref>) and is accessible through GEO Series GSE157714.</p><p>To identify novel cryptic exons present in the data, genomic alignment BAM files were generated using HISAT2 v.2.1.0 (<xref ref-type="bibr" rid="bib31">Kim et al., 2015</xref>), aligned to mouse reference genome GRCm38 (Ensembl 94 release) (<xref ref-type="bibr" rid="bib11">Cunningham et al., 2019</xref>). The RNA-seq reads aligned to <italic>Nfasc</italic> were visualized using the Bioconductor R package Gviz v.1.28.3 (<xref ref-type="bibr" rid="bib27">Hahne and Ivanek, 2016</xref>). TDP-43 CLIP-seq data from adult mouse brains from Yeo and Cleveland groups (GEO Series GSE40651) (<xref ref-type="bibr" rid="bib53">Polymenidou et al., 2011</xref>) was used to visualize TDP-43 mRNA binding sites. The number of reads spanning different exon–exon junctions was extracted from the alignment BAM files using Regtools v.0.5.1 junctions extract function (<xref ref-type="bibr" rid="bib23">Feng et al., 2018</xref>). This information was then used to calculate the PSI values for junctions of interest. PSI values reflect the efficiency of a specific exon being spliced in the transcript population and are calculated as the ratio of inclusion reads (reads spliced to exon of interest) to the sum of inclusion and exclusion reads (reads spliced to other exons).</p></sec><sec id="s4-11"><title>Statistical analysis</title><p>Except electrophysiological recordings and electron microscopy, the other data analysis was not performed in a blinded way. Sample size was not determined in advance using any statistical method, but is comparable to the one used in the literature of the field (<xref ref-type="bibr" rid="bib66">Susuki et al., 2018</xref>). Sets of age-matched WT, cHet, and cKO mice from the same litter or from two litters that had the closest dates of birth were randomly assigned together for analysis. The gender of the mice was recorded and not controlled; the gender did not affect the reproducibility of our study. One-way analysis of variance (ANOVA) tests with Tukey’s post-hoc analysis, Mann–Whitney tests, and unpaired two-tailed <italic>t</italic>-tests were conducted using OriginPro (OriginLab). The data points of five or less were assumed to be drawn from normal distributions. For the ANOVA tests, homogeneity of variance was not rejected by Levene’s tests. Biological replication is achieved by analyzing different mice. Technical replication is achieved by repeating the experiments using the same samples. The number of mice or technical replicates used for each comparison is described in the figure legends and Materials and methods. No data points were excluded except that one WT mouse in the rotarod test was considered an outlier, which may have learned that the consequences of falling are innocuous (<xref ref-type="bibr" rid="bib6">Brooks and Dunnett, 2009</xref>). Using the interquartile range method, it is far below the lower outlier fence ( = Q1 − IQR ×1.5). The detailed information on this excluded mouse can be found in <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Dr. Ueli Suter (ETH Zurich) for providing the <italic>Mpz-CreERT2</italic> mouse line, Dr. Dies Meijer (University of Edinburgh) for the <italic>Dhh-Cre</italic> mouse line, Dr. Klaus-Armin Nave (Max Planck Institute of Experimental Medicine) for the <italic>Cnp-Cre</italic> mouse line, and Dr. Scott S Zamvil (UCSF) for the access to the rotarod apparatus. We thank all the members of the Chan laboratory for many insightful discussions, advice, and encouragement. This work was supported by funding from the National Institutes of Health/National Institute of Neurological Disorders and Stroke (grants R01NS062796, R01NS097428, and R01NS095889), the Dr. Miriam and Sheldon G Adelson Medical Research Foundation (APND grant A130141), the Rachleff family endowment to JRC, the Israel Science Foundation and the Dr. Miriam and Sheldon G Adelson Medical Research Foundation to EP, the National Medical Research Council, Singapore (NMRC/OFIRG/0001/2016 and NMRC/OFIRG/0042/2017), and the Swee Liew-Wadsworth Endowment fund, National University of Singapore to SCL, the National Institutes of Health/National Institute of Neurological Disorders and Stroke (grants R01NS107398 and R03NS112981) to KS, and the National Multiple Sclerosis Society Postdoctoral Fellowship (FG-1507-05195) to KJC. EP is the Incumbent of the Hanna Hertz Professorial Chair for Multiple Sclerosis and Neuroscience.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Investigation</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Supervision, Investigation, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con7"><p>Data curation, Formal analysis, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Formal analysis, Supervision, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All experiments involving mice were performed in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals or the Association for Assessment and Accreditation of Laboratory Animal Care guidelines for animal use, and were pre-approved by the Institutional Animal Care and Use Committees at the University of California, San Francisco (protocol number: AN180003), National University of Singapore (protocol numbers: BR17-0928 and R17-0634), and Wright State University (Animal Use Protocol # 1113).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>The exon nomenclature of <italic>Nfasc</italic> used in this study.</title><p>The exon information was compiled from the current Ensembl database. The coordinates of each exon in chromosome 1 are shown (GRCm38.p6). Transcription starts from either exon 1a or 1b and terminates at either exon 23T or 33. The alternative exons specific for NF155 (exons 23 or 23L and 24) and the ones for NF186 (exons 28–30) are shaded in blue. Other alternative exons are shaded in gray. The cryptic exon CE1 identified in this study is shaded in pink. The start codon and potential stop codons are framed in red.</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-64456-supp1-v1.docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-64456-transrepform-v1.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>NCBI Gene Expression Omnibus, GSE157714.</p><p>The following previously published dataset was used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Yeo</surname><given-names>GW</given-names></name><name><surname>Cleveland</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2011">2011</year><data-title>Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs (CLIP-Seq)</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE40651">GSE40651</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amor</surname> <given-names>V</given-names></name><name><surname>Zhang</surname> <given-names>C</given-names></name><name><surname>Vainshtein</surname> <given-names>A</given-names></name><name><surname>Zhang</surname> <given-names>A</given-names></name><name><surname>Zollinger</surname> <given-names>DR</given-names></name><name><surname>Eshed-Eisenbach</surname> <given-names>Y</given-names></name><name><surname>Brophy</surname> <given-names>PJ</given-names></name><name><surname>Rasband</surname> <given-names>MN</given-names></name><name><surname>Peles</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The paranodal cytoskeleton clusters Na<sup>+</sup> channels at nodes of Ranvier</article-title><source>eLife</source><volume>6</volume><elocation-id>e21392</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.21392</pub-id><pub-id pub-id-type="pmid">28134616</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arai</surname> <given-names>T</given-names></name><name><surname>Hasegawa</surname> <given-names>M</given-names></name><name><surname>Akiyama</surname> <given-names>H</given-names></name><name><surname>Ikeda</surname> <given-names>K</given-names></name><name><surname>Nonaka</surname> <given-names>T</given-names></name><name><surname>Mori</surname> <given-names>H</given-names></name><name><surname>Mann</surname> <given-names>D</given-names></name><name><surname>Tsuchiya</surname> <given-names>K</given-names></name><name><surname>Yoshida</surname> <given-names>M</given-names></name><name><surname>Hashizume</surname> <given-names>Y</given-names></name><name><surname>Oda</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis</article-title><source>Biochemical and Biophysical Research Communications</source><volume>351</volume><fpage>602</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2006.10.093</pub-id><pub-id pub-id-type="pmid">17084815</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basak</surname> <given-names>S</given-names></name><name><surname>Raju</surname> <given-names>K</given-names></name><name><surname>Babiarz</surname> <given-names>J</given-names></name><name><surname>Kane-Goldsmith</surname> <given-names>N</given-names></name><name><surname>Koticha</surname> <given-names>D</given-names></name><name><surname>Grumet</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Differential expression and functions of neuronal and glial neurofascin isoforms and splice variants during PNS development</article-title><source>Developmental Biology</source><volume>311</volume><fpage>408</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2007.08.045</pub-id><pub-id pub-id-type="pmid">17936266</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berglund</surname> <given-names>EO</given-names></name><name><surname>Murai</surname> <given-names>KK</given-names></name><name><surname>Fredette</surname> <given-names>B</given-names></name><name><surname>Sekerková</surname> <given-names>G</given-names></name><name><surname>Marturano</surname> <given-names>B</given-names></name><name><surname>Weber</surname> <given-names>L</given-names></name><name><surname>Mugnaini</surname> <given-names>E</given-names></name><name><surname>Ranscht</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Ataxia and abnormal cerebellar microorganization in mice with ablated contactin gene expression</article-title><source>Neuron</source><volume>24</volume><fpage>739</fpage><lpage>750</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)81126-5</pub-id><pub-id pub-id-type="pmid">10595523</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhat</surname> <given-names>MA</given-names></name><name><surname>Rios</surname> <given-names>JC</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Garcia-Fresco</surname> <given-names>GP</given-names></name><name><surname>Ching</surname> <given-names>W</given-names></name><name><surname>St Martin</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Einheber</surname> <given-names>S</given-names></name><name><surname>Chesler</surname> <given-names>M</given-names></name><name><surname>Rosenbluth</surname> <given-names>J</given-names></name><name><surname>Salzer</surname> <given-names>JL</given-names></name><name><surname>Bellen</surname> <given-names>HJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Axon-glia interactions and the domain organization of myelinated axons requires neurexin IV/Caspr/Paranodin</article-title><source>Neuron</source><volume>30</volume><fpage>369</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(01)00294-X</pub-id><pub-id pub-id-type="pmid">11395000</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brooks</surname> <given-names>SP</given-names></name><name><surname>Dunnett</surname> <given-names>SB</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Tests to assess motor phenotype in mice: a user's guide</article-title><source>Nature Reviews Neuroscience</source><volume>10</volume><fpage>519</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1038/nrn2652</pub-id><pub-id pub-id-type="pmid">19513088</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>KJ</given-names></name><name><surname>Zollinger</surname> <given-names>DR</given-names></name><name><surname>Susuki</surname> <given-names>K</given-names></name><name><surname>Sherman</surname> <given-names>DL</given-names></name><name><surname>Makara</surname> <given-names>MA</given-names></name><name><surname>Brophy</surname> <given-names>PJ</given-names></name><name><surname>Cooper</surname> <given-names>EC</given-names></name><name><surname>Bennett</surname> <given-names>V</given-names></name><name><surname>Mohler</surname> <given-names>PJ</given-names></name><name><surname>Rasband</surname> <given-names>MN</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Glial ankyrins facilitate paranodal axoglial junction assembly</article-title><source>Nature Neuroscience</source><volume>17</volume><fpage>1673</fpage><lpage>1681</lpage><pub-id pub-id-type="doi">10.1038/nn.3858</pub-id><pub-id pub-id-type="pmid">25362471</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname> <given-names>KJ</given-names></name><name><surname>Redmond</surname> <given-names>SA</given-names></name><name><surname>Chan</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Remodeling myelination: implications for mechanisms of neural plasticity</article-title><source>Nature Neuroscience</source><volume>19</volume><fpage>190</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1038/nn.4200</pub-id><pub-id pub-id-type="pmid">26814588</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiang</surname> <given-names>PM</given-names></name><name><surname>Ling</surname> <given-names>J</given-names></name><name><surname>Jeong</surname> <given-names>YH</given-names></name><name><surname>Price</surname> <given-names>DL</given-names></name><name><surname>Aja</surname> <given-names>SM</given-names></name><name><surname>Wong</surname> <given-names>PC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism</article-title><source>PNAS</source><volume>107</volume><fpage>16320</fpage><lpage>16324</lpage><pub-id pub-id-type="doi">10.1073/pnas.1002176107</pub-id><pub-id pub-id-type="pmid">20660762</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coetzee</surname> <given-names>T</given-names></name><name><surname>Fujita</surname> <given-names>N</given-names></name><name><surname>Dupree</surname> <given-names>J</given-names></name><name><surname>Shi</surname> <given-names>R</given-names></name><name><surname>Blight</surname> <given-names>A</given-names></name><name><surname>Suzuki</surname> <given-names>K</given-names></name><name><surname>Suzuki</surname> <given-names>K</given-names></name><name><surname>Popko</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability</article-title><source>Cell</source><volume>86</volume><fpage>209</fpage><lpage>219</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80093-8</pub-id><pub-id pub-id-type="pmid">8706126</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname> <given-names>F</given-names></name><name><surname>Achuthan</surname> <given-names>P</given-names></name><name><surname>Akanni</surname> <given-names>W</given-names></name><name><surname>Allen</surname> <given-names>J</given-names></name><name><surname>Amode</surname> <given-names>MR</given-names></name><name><surname>Armean</surname> <given-names>IM</given-names></name><name><surname>Bennett</surname> <given-names>R</given-names></name><name><surname>Bhai</surname> <given-names>J</given-names></name><name><surname>Billis</surname> <given-names>K</given-names></name><name><surname>Boddu</surname> <given-names>S</given-names></name><name><surname>Cummins</surname> <given-names>C</given-names></name><name><surname>Davidson</surname> <given-names>C</given-names></name><name><surname>Dodiya</surname> <given-names>KJ</given-names></name><name><surname>Gall</surname> <given-names>A</given-names></name><name><surname>Girón</surname> <given-names>CG</given-names></name><name><surname>Gil</surname> <given-names>L</given-names></name><name><surname>Grego</surname> <given-names>T</given-names></name><name><surname>Haggerty</surname> <given-names>L</given-names></name><name><surname>Haskell</surname> <given-names>E</given-names></name><name><surname>Hourlier</surname> <given-names>T</given-names></name><name><surname>Izuogu</surname> <given-names>OG</given-names></name><name><surname>Janacek</surname> <given-names>SH</given-names></name><name><surname>Juettemann</surname> <given-names>T</given-names></name><name><surname>Kay</surname> <given-names>M</given-names></name><name><surname>Laird</surname> <given-names>MR</given-names></name><name><surname>Lavidas</surname> <given-names>I</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Loveland</surname> <given-names>JE</given-names></name><name><surname>Marugán</surname> <given-names>JC</given-names></name><name><surname>Maurel</surname> <given-names>T</given-names></name><name><surname>McMahon</surname> <given-names>AC</given-names></name><name><surname>Moore</surname> <given-names>B</given-names></name><name><surname>Morales</surname> <given-names>J</given-names></name><name><surname>Mudge</surname> <given-names>JM</given-names></name><name><surname>Nuhn</surname> <given-names>M</given-names></name><name><surname>Ogeh</surname> <given-names>D</given-names></name><name><surname>Parker</surname> <given-names>A</given-names></name><name><surname>Parton</surname> <given-names>A</given-names></name><name><surname>Patricio</surname> <given-names>M</given-names></name><name><surname>Abdul Salam</surname> <given-names>AI</given-names></name><name><surname>Schmitt</surname> <given-names>BM</given-names></name><name><surname>Schuilenburg</surname> <given-names>H</given-names></name><name><surname>Sheppard</surname> <given-names>D</given-names></name><name><surname>Sparrow</surname> <given-names>H</given-names></name><name><surname>Stapleton</surname> <given-names>E</given-names></name><name><surname>Szuba</surname> <given-names>M</given-names></name><name><surname>Taylor</surname> <given-names>K</given-names></name><name><surname>Threadgold</surname> <given-names>G</given-names></name><name><surname>Thormann</surname> <given-names>A</given-names></name><name><surname>Vullo</surname> <given-names>A</given-names></name><name><surname>Walts</surname> <given-names>B</given-names></name><name><surname>Winterbottom</surname> <given-names>A</given-names></name><name><surname>Zadissa</surname> <given-names>A</given-names></name><name><surname>Chakiachvili</surname> <given-names>M</given-names></name><name><surname>Frankish</surname> <given-names>A</given-names></name><name><surname>Hunt</surname> <given-names>SE</given-names></name><name><surname>Kostadima</surname> <given-names>M</given-names></name><name><surname>Langridge</surname> <given-names>N</given-names></name><name><surname>Martin</surname> <given-names>FJ</given-names></name><name><surname>Muffato</surname> <given-names>M</given-names></name><name><surname>Perry</surname> <given-names>E</given-names></name><name><surname>Ruffier</surname> <given-names>M</given-names></name><name><surname>Staines</surname> <given-names>DM</given-names></name><name><surname>Trevanion</surname> <given-names>SJ</given-names></name><name><surname>Aken</surname> <given-names>BL</given-names></name><name><surname>Yates</surname> <given-names>AD</given-names></name><name><surname>Zerbino</surname> <given-names>DR</given-names></name><name><surname>Flicek</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ensembl 2019</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D745</fpage><lpage>D751</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1113</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname> <given-names>JQ</given-names></name><name><surname>McLaughlin</surname> <given-names>T</given-names></name><name><surname>Bennett</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Ankyrin-binding proteins related to nervous system cell adhesion molecules: candidates to provide transmembrane and intercellular connections in adult brain</article-title><source>Journal of Cell Biology</source><volume>121</volume><fpage>121</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1083/jcb.121.1.121</pub-id><pub-id pub-id-type="pmid">8458865</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname> <given-names>JQ</given-names></name><name><surname>Lambert</surname> <given-names>S</given-names></name><name><surname>Bennett</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Molecular composition of the node of Ranvier: identification of ankyrin-binding cell adhesion molecules neurofascin (mucin+/third FNIII domain-) and NrCAM at nodal axon segments</article-title><source>Journal of Cell Biology</source><volume>135</volume><fpage>1355</fpage><lpage>1367</lpage><pub-id pub-id-type="doi">10.1083/jcb.135.5.1355</pub-id><pub-id pub-id-type="pmid">8947556</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desmazieres</surname> <given-names>A</given-names></name><name><surname>Zonta</surname> <given-names>B</given-names></name><name><surname>Zhang</surname> <given-names>A</given-names></name><name><surname>Wu</surname> <given-names>LM</given-names></name><name><surname>Sherman</surname> <given-names>DL</given-names></name><name><surname>Brophy</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Differential stability of PNS and CNS nodal complexes when neuronal neurofascin is lost</article-title><source>Journal of Neuroscience</source><volume>34</volume><fpage>5083</fpage><lpage>5088</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4662-13.2014</pub-id><pub-id pub-id-type="pmid">24719087</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ederle</surname> <given-names>H</given-names></name><name><surname>Dormann</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>TDP-43 and FUS <italic>en route</italic> from the nucleus to the cytoplasm</article-title><source>FEBS Letters</source><volume>591</volume><fpage>1489</fpage><lpage>1507</lpage><pub-id pub-id-type="doi">10.1002/1873-3468.12646</pub-id><pub-id pub-id-type="pmid">28380257</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgar</surname> <given-names>R</given-names></name><name><surname>Domrachev</surname> <given-names>M</given-names></name><name><surname>Lash</surname> <given-names>AE</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Gene expression omnibus: NCBI gene expression and hybridization array data repository</article-title><source>Nucleic Acids Research</source><volume>30</volume><fpage>207</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1093/nar/30.1.207</pub-id><pub-id pub-id-type="pmid">11752295</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eshed</surname> <given-names>Y</given-names></name><name><surname>Feinberg</surname> <given-names>K</given-names></name><name><surname>Poliak</surname> <given-names>S</given-names></name><name><surname>Sabanay</surname> <given-names>H</given-names></name><name><surname>Sarig-Nadir</surname> <given-names>O</given-names></name><name><surname>Spiegel</surname> <given-names>I</given-names></name><name><surname>Bermingham</surname> <given-names>JR</given-names></name><name><surname>Peles</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier</article-title><source>Neuron</source><volume>47</volume><fpage>215</fpage><lpage>229</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2005.06.026</pub-id><pub-id pub-id-type="pmid">16039564</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eshed</surname> <given-names>Y</given-names></name><name><surname>Feinberg</surname> <given-names>K</given-names></name><name><surname>Carey</surname> <given-names>DJ</given-names></name><name><surname>Peles</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Secreted gliomedin is a perinodal matrix component of peripheral nerves</article-title><source>Journal of Cell Biology</source><volume>177</volume><fpage>551</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1083/jcb.200612139</pub-id><pub-id pub-id-type="pmid">17485493</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eshed-Eisenbach</surname> <given-names>Y</given-names></name><name><surname>Devaux</surname> <given-names>J</given-names></name><name><surname>Vainshtein</surname> <given-names>A</given-names></name><name><surname>Golani</surname> <given-names>O</given-names></name><name><surname>Lee</surname> <given-names>SJ</given-names></name><name><surname>Feinberg</surname> <given-names>K</given-names></name><name><surname>Sukhanov</surname> <given-names>N</given-names></name><name><surname>Greenspan</surname> <given-names>DS</given-names></name><name><surname>Susuki</surname> <given-names>K</given-names></name><name><surname>Rasband</surname> <given-names>MN</given-names></name><name><surname>Peles</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Precise spatiotemporal control of nodal Na<sup>+</sup> channel clustering by bone morphogenetic protein-1/Tolloid-like proteinases</article-title><source>Neuron</source><volume>106</volume><fpage>806</fpage><lpage>815</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2020.03.001</pub-id><pub-id pub-id-type="pmid">32209430</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feinberg</surname> <given-names>K</given-names></name><name><surname>Eshed-Eisenbach</surname> <given-names>Y</given-names></name><name><surname>Frechter</surname> <given-names>S</given-names></name><name><surname>Amor</surname> <given-names>V</given-names></name><name><surname>Salomon</surname> <given-names>D</given-names></name><name><surname>Sabanay</surname> <given-names>H</given-names></name><name><surname>Dupree</surname> <given-names>JL</given-names></name><name><surname>Grumet</surname> <given-names>M</given-names></name><name><surname>Brophy</surname> <given-names>PJ</given-names></name><name><surname>Shrager</surname> <given-names>P</given-names></name><name><surname>Peles</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A glial signal consisting of gliomedin and NrCAM clusters axonal Na<sup>+</sup> channels during the formation of nodes of Ranvier</article-title><source>Neuron</source><volume>65</volume><fpage>490</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2010.02.004</pub-id><pub-id pub-id-type="pmid">20188654</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feltri</surname> <given-names>ML</given-names></name><name><surname>D'Antonio</surname> <given-names>M</given-names></name><name><surname>Previtali</surname> <given-names>S</given-names></name><name><surname>Fasolini</surname> <given-names>M</given-names></name><name><surname>Messing</surname> <given-names>A</given-names></name><name><surname>Wrabetz</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>P0-Cre transgenic mice for inactivation of adhesion molecules in Schwann cells</article-title><source>Annals of the New York Academy of Sciences</source><volume>883</volume><fpage>116</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.1999.tb08574.x</pub-id><pub-id pub-id-type="pmid">10586237</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feltri</surname> <given-names>ML</given-names></name><name><surname>Graus Porta</surname> <given-names>D</given-names></name><name><surname>Previtali</surname> <given-names>SC</given-names></name><name><surname>Nodari</surname> <given-names>A</given-names></name><name><surname>Migliavacca</surname> <given-names>B</given-names></name><name><surname>Cassetti</surname> <given-names>A</given-names></name><name><surname>Littlewood-Evans</surname> <given-names>A</given-names></name><name><surname>Reichardt</surname> <given-names>LF</given-names></name><name><surname>Messing</surname> <given-names>A</given-names></name><name><surname>Quattrini</surname> <given-names>A</given-names></name><name><surname>Mueller</surname> <given-names>U</given-names></name><name><surname>Wrabetz</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Conditional disruption of β1 integrin in Schwann cells impedes interactions with axons</article-title><source>Journal of Cell Biology</source><volume>156</volume><fpage>199</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1083/jcb.200109021</pub-id><pub-id pub-id-type="pmid">11777940</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Feng</surname> <given-names>YY</given-names></name><name><surname>Ramu</surname> <given-names>A</given-names></name><name><surname>Cotto</surname> <given-names>KC</given-names></name><name><surname>Skidmore</surname> <given-names>ZL</given-names></name><name><surname>Kunisaki</surname> <given-names>J</given-names></name><name><surname>Conrad</surname> <given-names>DF</given-names></name><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Chapman</surname> <given-names>WC</given-names></name><name><surname>Uppaluri</surname> <given-names>R</given-names></name><name><surname>Govindan</surname> <given-names>R</given-names></name><name><surname>Griffith</surname> <given-names>OL</given-names></name><name><surname>Griffith</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>RegTools: integrated analysis of genomic and transcriptomic data for discovery of splicing variants in cancer</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/436634</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname> <given-names>XD</given-names></name><name><surname>Ares</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Context-dependent control of alternative splicing by RNA-binding proteins</article-title><source>Nature Reviews. Genetics</source><volume>15</volume><fpage>689</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1038/nrg3778</pub-id><pub-id pub-id-type="pmid">25112293</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gentile</surname> <given-names>F</given-names></name><name><surname>Scarlino</surname> <given-names>S</given-names></name><name><surname>Falzone</surname> <given-names>YM</given-names></name><name><surname>Lunetta</surname> <given-names>C</given-names></name><name><surname>Tremolizzo</surname> <given-names>L</given-names></name><name><surname>Quattrini</surname> <given-names>A</given-names></name><name><surname>Riva</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The peripheral nervous system in amyotrophic lateral sclerosis: opportunities for translational research</article-title><source>Frontiers in Neuroscience</source><volume>13</volume><elocation-id>601</elocation-id><pub-id pub-id-type="doi">10.3389/fnins.2019.00601</pub-id><pub-id pub-id-type="pmid">31293369</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gollan</surname> <given-names>L</given-names></name><name><surname>Salomon</surname> <given-names>D</given-names></name><name><surname>Salzer</surname> <given-names>JL</given-names></name><name><surname>Peles</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Caspr regulates the processing of contactin and inhibits its binding to neurofascin</article-title><source>Journal of Cell Biology</source><volume>163</volume><fpage>1213</fpage><lpage>1218</lpage><pub-id pub-id-type="doi">10.1083/jcb.200309147</pub-id><pub-id pub-id-type="pmid">14676309</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hahne</surname> <given-names>F</given-names></name><name><surname>Ivanek</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Visualizing genomic data using Gviz and Bioconductor</article-title><source>Methods in Molecular Biology</source><volume>1418</volume><fpage>335</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-3578-9_16</pub-id><pub-id pub-id-type="pmid">27008022</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iguchi</surname> <given-names>Y</given-names></name><name><surname>Katsuno</surname> <given-names>M</given-names></name><name><surname>Niwa</surname> <given-names>J</given-names></name><name><surname>Takagi</surname> <given-names>S</given-names></name><name><surname>Ishigaki</surname> <given-names>S</given-names></name><name><surname>Ikenaka</surname> <given-names>K</given-names></name><name><surname>Kawai</surname> <given-names>K</given-names></name><name><surname>Watanabe</surname> <given-names>H</given-names></name><name><surname>Yamanaka</surname> <given-names>K</given-names></name><name><surname>Takahashi</surname> <given-names>R</given-names></name><name><surname>Misawa</surname> <given-names>H</given-names></name><name><surname>Sasaki</surname> <given-names>S</given-names></name><name><surname>Tanaka</surname> <given-names>F</given-names></name><name><surname>Sobue</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Loss of TDP-43 causes age-dependent progressive motor neuron degeneration</article-title><source>Brain</source><volume>136</volume><fpage>1371</fpage><lpage>1382</lpage><pub-id pub-id-type="doi">10.1093/brain/awt029</pub-id><pub-id pub-id-type="pmid">23449777</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaegle</surname> <given-names>M</given-names></name><name><surname>Ghazvini</surname> <given-names>M</given-names></name><name><surname>Mandemakers</surname> <given-names>W</given-names></name><name><surname>Piirsoo</surname> <given-names>M</given-names></name><name><surname>Driegen</surname> <given-names>S</given-names></name><name><surname>Levavasseur</surname> <given-names>F</given-names></name><name><surname>Raghoenath</surname> <given-names>S</given-names></name><name><surname>Grosveld</surname> <given-names>F</given-names></name><name><surname>Meijer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The POU proteins Brn-2 and Oct-6 share important functions in Schwann cell development</article-title><source>Genes &amp; Development</source><volume>17</volume><fpage>1380</fpage><lpage>1391</lpage><pub-id pub-id-type="doi">10.1101/gad.258203</pub-id><pub-id pub-id-type="pmid">12782656</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karousis</surname> <given-names>ED</given-names></name><name><surname>Mühlemann</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Nonsense-mediated mRNA decay begins where translation ends</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>11</volume><elocation-id>a032862</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a032862</pub-id><pub-id pub-id-type="pmid">29891560</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>D</given-names></name><name><surname>Langmead</surname> <given-names>B</given-names></name><name><surname>Salzberg</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HISAT: a fast spliced aligner with low memory requirements</article-title><source>Nature Methods</source><volume>12</volume><fpage>357</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3317</pub-id><pub-id pub-id-type="pmid">25751142</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klim</surname> <given-names>JR</given-names></name><name><surname>Williams</surname> <given-names>LA</given-names></name><name><surname>Limone</surname> <given-names>F</given-names></name><name><surname>Guerra San Juan</surname> <given-names>I</given-names></name><name><surname>Davis-Dusenbery</surname> <given-names>BN</given-names></name><name><surname>Mordes</surname> <given-names>DA</given-names></name><name><surname>Burberry</surname> <given-names>A</given-names></name><name><surname>Steinbaugh</surname> <given-names>MJ</given-names></name><name><surname>Gamage</surname> <given-names>KK</given-names></name><name><surname>Kirchner</surname> <given-names>R</given-names></name><name><surname>Moccia</surname> <given-names>R</given-names></name><name><surname>Cassel</surname> <given-names>SH</given-names></name><name><surname>Chen</surname> <given-names>K</given-names></name><name><surname>Wainger</surname> <given-names>BJ</given-names></name><name><surname>Woolf</surname> <given-names>CJ</given-names></name><name><surname>Eggan</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair</article-title><source>Nature Neuroscience</source><volume>22</volume><fpage>167</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0300-4</pub-id><pub-id pub-id-type="pmid">30643292</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwong</surname> <given-names>LK</given-names></name><name><surname>Uryu</surname> <given-names>K</given-names></name><name><surname>Trojanowski</surname> <given-names>JQ</given-names></name><name><surname>Lee</surname> <given-names>VM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>TDP-43 proteinopathies: neurodegenerative protein misfolding diseases without amyloidosis</article-title><source>Neurosignals</source><volume>16</volume><fpage>41</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1159/000109758</pub-id><pub-id pub-id-type="pmid">18097159</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lappe-Siefke</surname> <given-names>C</given-names></name><name><surname>Goebbels</surname> <given-names>S</given-names></name><name><surname>Gravel</surname> <given-names>M</given-names></name><name><surname>Nicksch</surname> <given-names>E</given-names></name><name><surname>Lee</surname> <given-names>J</given-names></name><name><surname>Braun</surname> <given-names>PE</given-names></name><name><surname>Griffiths</surname> <given-names>IR</given-names></name><name><surname>Nave</surname> <given-names>KA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination</article-title><source>Nature Genetics</source><volume>33</volume><fpage>366</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1038/ng1095</pub-id><pub-id pub-id-type="pmid">12590258</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leone</surname> <given-names>DP</given-names></name><name><surname>Genoud</surname> <given-names>S</given-names></name><name><surname>Atanasoski</surname> <given-names>S</given-names></name><name><surname>Grausenburger</surname> <given-names>R</given-names></name><name><surname>Berger</surname> <given-names>P</given-names></name><name><surname>Metzger</surname> <given-names>D</given-names></name><name><surname>Macklin</surname> <given-names>WB</given-names></name><name><surname>Chambon</surname> <given-names>P</given-names></name><name><surname>Suter</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells</article-title><source>Molecular and Cellular Neuroscience</source><volume>22</volume><fpage>430</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1016/S1044-7431(03)00029-0</pub-id><pub-id pub-id-type="pmid">12727441</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname> <given-names>SC</given-names></name><name><surname>Polymenidou</surname> <given-names>M</given-names></name><name><surname>Cleveland</surname> <given-names>DW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis</article-title><source>Neuron</source><volume>79</volume><fpage>416</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.07.033</pub-id><pub-id pub-id-type="pmid">23931993</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ling</surname> <given-names>JP</given-names></name><name><surname>Pletnikova</surname> <given-names>O</given-names></name><name><surname>Troncoso</surname> <given-names>JC</given-names></name><name><surname>Wong</surname> <given-names>PC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD</article-title><source>Science</source><volume>349</volume><fpage>650</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1126/science.aab0983</pub-id><pub-id pub-id-type="pmid">26250685</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melamed</surname> <given-names>Z</given-names></name><name><surname>López-Erauskin</surname> <given-names>J</given-names></name><name><surname>Baughn</surname> <given-names>MW</given-names></name><name><surname>Zhang</surname> <given-names>O</given-names></name><name><surname>Drenner</surname> <given-names>K</given-names></name><name><surname>Sun</surname> <given-names>Y</given-names></name><name><surname>Freyermuth</surname> <given-names>F</given-names></name><name><surname>McMahon</surname> <given-names>MA</given-names></name><name><surname>Beccari</surname> <given-names>MS</given-names></name><name><surname>Artates</surname> <given-names>JW</given-names></name><name><surname>Ohkubo</surname> <given-names>T</given-names></name><name><surname>Rodriguez</surname> <given-names>M</given-names></name><name><surname>Lin</surname> <given-names>N</given-names></name><name><surname>Wu</surname> <given-names>D</given-names></name><name><surname>Bennett</surname> <given-names>CF</given-names></name><name><surname>Rigo</surname> <given-names>F</given-names></name><name><surname>Da Cruz</surname> <given-names>S</given-names></name><name><surname>Ravits</surname> <given-names>J</given-names></name><name><surname>Lagier-Tourenne</surname> <given-names>C</given-names></name><name><surname>Cleveland</surname> <given-names>DW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration</article-title><source>Nature Neuroscience</source><volume>22</volume><fpage>180</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1038/s41593-018-0293-z</pub-id><pub-id pub-id-type="pmid">30643298</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monk</surname> <given-names>KR</given-names></name><name><surname>Feltri</surname> <given-names>ML</given-names></name><name><surname>Taveggia</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>New insights on Schwann cell development</article-title><source>Glia</source><volume>63</volume><fpage>1376</fpage><lpage>1393</lpage><pub-id pub-id-type="doi">10.1002/glia.22852</pub-id><pub-id pub-id-type="pmid">25921593</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura-Shindo</surname> <given-names>K</given-names></name><name><surname>Sakai</surname> <given-names>K</given-names></name><name><surname>Shimizu</surname> <given-names>A</given-names></name><name><surname>Ishida</surname> <given-names>C</given-names></name><name><surname>Yamada</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Accumulation of phosphorylated TDP-43 in the cytoplasm of Schwann cells in a case of sporadic amyotrophic lateral sclerosis</article-title><source>Neuropathology</source><volume>40</volume><fpage>606</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1111/neup.12673</pub-id><pub-id pub-id-type="pmid">32776323</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nave</surname> <given-names>KA</given-names></name><name><surname>Werner</surname> <given-names>HB</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Myelination of the nervous system: mechanisms and functions</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>30</volume><fpage>503</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-100913-013101</pub-id><pub-id pub-id-type="pmid">25288117</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname> <given-names>M</given-names></name><name><surname>Sampathu</surname> <given-names>DM</given-names></name><name><surname>Kwong</surname> <given-names>LK</given-names></name><name><surname>Truax</surname> <given-names>AC</given-names></name><name><surname>Micsenyi</surname> <given-names>MC</given-names></name><name><surname>Chou</surname> <given-names>TT</given-names></name><name><surname>Bruce</surname> <given-names>J</given-names></name><name><surname>Schuck</surname> <given-names>T</given-names></name><name><surname>Grossman</surname> <given-names>M</given-names></name><name><surname>Clark</surname> <given-names>CM</given-names></name><name><surname>McCluskey</surname> <given-names>LF</given-names></name><name><surname>Miller</surname> <given-names>BL</given-names></name><name><surname>Masliah</surname> <given-names>E</given-names></name><name><surname>Mackenzie</surname> <given-names>IR</given-names></name><name><surname>Feldman</surname> <given-names>H</given-names></name><name><surname>Feiden</surname> <given-names>W</given-names></name><name><surname>Kretzschmar</surname> <given-names>HA</given-names></name><name><surname>Trojanowski</surname> <given-names>JQ</given-names></name><name><surname>Lee</surname> <given-names>VM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis</article-title><source>Science</source><volume>314</volume><fpage>130</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1126/science.1134108</pub-id><pub-id pub-id-type="pmid">17023659</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otani</surname> <given-names>Y</given-names></name><name><surname>Yermakov</surname> <given-names>LM</given-names></name><name><surname>Dupree</surname> <given-names>JL</given-names></name><name><surname>Susuki</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Chronic peripheral nerve compression disrupts paranodal axoglial junctions</article-title><source>Muscle &amp; Nerve</source><volume>55</volume><fpage>544</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1002/mus.25273</pub-id><pub-id pub-id-type="pmid">27463510</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paolicelli</surname> <given-names>RC</given-names></name><name><surname>Jawaid</surname> <given-names>A</given-names></name><name><surname>Henstridge</surname> <given-names>CM</given-names></name><name><surname>Valeri</surname> <given-names>A</given-names></name><name><surname>Merlini</surname> <given-names>M</given-names></name><name><surname>Robinson</surname> <given-names>JL</given-names></name><name><surname>Lee</surname> <given-names>EB</given-names></name><name><surname>Rose</surname> <given-names>J</given-names></name><name><surname>Appel</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>VM</given-names></name><name><surname>Trojanowski</surname> <given-names>JQ</given-names></name><name><surname>Spires-Jones</surname> <given-names>T</given-names></name><name><surname>Schulz</surname> <given-names>PE</given-names></name><name><surname>Rajendran</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>TDP-43 depletion in microglia promotes amyloid clearance but also induces synapse loss</article-title><source>Neuron</source><volume>95</volume><fpage>297</fpage><lpage>308</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.05.037</pub-id><pub-id pub-id-type="pmid">28669544</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patzig</surname> <given-names>J</given-names></name><name><surname>Jahn</surname> <given-names>O</given-names></name><name><surname>Tenzer</surname> <given-names>S</given-names></name><name><surname>Wichert</surname> <given-names>SP</given-names></name><name><surname>de Monasterio-Schrader</surname> <given-names>P</given-names></name><name><surname>Rosfa</surname> <given-names>S</given-names></name><name><surname>Kuharev</surname> <given-names>J</given-names></name><name><surname>Yan</surname> <given-names>K</given-names></name><name><surname>Bormuth</surname> <given-names>I</given-names></name><name><surname>Bremer</surname> <given-names>J</given-names></name><name><surname>Aguzzi</surname> <given-names>A</given-names></name><name><surname>Orfaniotou</surname> <given-names>F</given-names></name><name><surname>Hesse</surname> <given-names>D</given-names></name><name><surname>Schwab</surname> <given-names>MH</given-names></name><name><surname>Möbius</surname> <given-names>W</given-names></name><name><surname>Nave</surname> <given-names>KA</given-names></name><name><surname>Werner</surname> <given-names>HB</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Quantitative and integrative proteome analysis of peripheral nerve myelin identifies novel myelin proteins and candidate neuropathy loci</article-title><source>Journal of Neuroscience</source><volume>31</volume><fpage>16369</fpage><lpage>16386</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4016-11.2011</pub-id><pub-id pub-id-type="pmid">22072688</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedraza</surname> <given-names>L</given-names></name><name><surname>Huang</surname> <given-names>JK</given-names></name><name><surname>Colman</surname> <given-names>DR</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Organizing principles of the axoglial apparatus</article-title><source>Neuron</source><volume>30</volume><fpage>335</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(01)00306-3</pub-id><pub-id pub-id-type="pmid">11394997</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peles</surname> <given-names>E</given-names></name><name><surname>Nativ</surname> <given-names>M</given-names></name><name><surname>Lustig</surname> <given-names>M</given-names></name><name><surname>Grumet</surname> <given-names>M</given-names></name><name><surname>Schilling</surname> <given-names>J</given-names></name><name><surname>Martinez</surname> <given-names>R</given-names></name><name><surname>Plowman</surname> <given-names>GD</given-names></name><name><surname>Schlessinger</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions</article-title><source>EMBO Journal</source><volume>16</volume><fpage>978</fpage><lpage>988</lpage><pub-id pub-id-type="doi">10.1093/emboj/16.5.978</pub-id><pub-id pub-id-type="pmid">9118959</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname> <given-names>AYT</given-names></name><name><surname>Agrawal</surname> <given-names>I</given-names></name><name><surname>Ho</surname> <given-names>WY</given-names></name><name><surname>Yen</surname> <given-names>YC</given-names></name><name><surname>Pinter</surname> <given-names>AJ</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Phua</surname> <given-names>QXC</given-names></name><name><surname>Koh</surname> <given-names>KB</given-names></name><name><surname>Chang</surname> <given-names>JC</given-names></name><name><surname>Sanford</surname> <given-names>E</given-names></name><name><surname>Man</surname> <given-names>JHK</given-names></name><name><surname>Wong</surname> <given-names>P</given-names></name><name><surname>Gutmann</surname> <given-names>DH</given-names></name><name><surname>Tucker-Kellogg</surname> <given-names>G</given-names></name><name><surname>Ling</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Loss of TDP-43 in astrocytes leads to motor deficits by triggering A1-like reactive phenotype and triglial dysfunction</article-title><source>PNAS</source><volume>117</volume><fpage>29101</fpage><lpage>29112</lpage><pub-id pub-id-type="doi">10.1073/pnas.2007806117</pub-id><pub-id pub-id-type="pmid">33127758</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pillai</surname> <given-names>AM</given-names></name><name><surname>Thaxton</surname> <given-names>C</given-names></name><name><surname>Pribisko</surname> <given-names>AL</given-names></name><name><surname>Cheng</surname> <given-names>JG</given-names></name><name><surname>Dupree</surname> <given-names>JL</given-names></name><name><surname>Bhat</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Spatiotemporal ablation of myelinating glia-specific <italic>neurofascin</italic> (<italic>Nfasc<sup>NF155</sup></italic>) in mice reveals gradual loss of paranodal axoglial junctions and concomitant disorganization of axonal domains</article-title><source>Journal of Neuroscience Research</source><volume>87</volume><fpage>1773</fpage><lpage>1793</lpage><pub-id pub-id-type="doi">10.1002/jnr.22015</pub-id><pub-id pub-id-type="pmid">19185024</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poliak</surname> <given-names>S</given-names></name><name><surname>Gollan</surname> <given-names>L</given-names></name><name><surname>Martinez</surname> <given-names>R</given-names></name><name><surname>Custer</surname> <given-names>A</given-names></name><name><surname>Einheber</surname> <given-names>S</given-names></name><name><surname>Salzer</surname> <given-names>JL</given-names></name><name><surname>Trimmer</surname> <given-names>JS</given-names></name><name><surname>Shrager</surname> <given-names>P</given-names></name><name><surname>Peles</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K<sup>+</sup> channels</article-title><source>Neuron</source><volume>24</volume><fpage>1037</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)81049-1</pub-id><pub-id pub-id-type="pmid">10624965</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poliak</surname> <given-names>S</given-names></name><name><surname>Gollan</surname> <given-names>L</given-names></name><name><surname>Salomon</surname> <given-names>D</given-names></name><name><surname>Berglund</surname> <given-names>EO</given-names></name><name><surname>Ohara</surname> <given-names>R</given-names></name><name><surname>Ranscht</surname> <given-names>B</given-names></name><name><surname>Peles</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Localization of Caspr2 in myelinated nerves depends on axon-glia interactions and the generation of barriers along the axon</article-title><source>Journal of Neuroscience</source><volume>21</volume><fpage>7568</fpage><lpage>7575</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-19-07568.2001</pub-id><pub-id pub-id-type="pmid">11567047</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poliak</surname> <given-names>S</given-names></name><name><surname>Peles</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The local differentiation of myelinated axons at nodes of Ranvier</article-title><source>Nature Reviews Neuroscience</source><volume>4</volume><fpage>968</fpage><lpage>980</lpage><pub-id pub-id-type="doi">10.1038/nrn1253</pub-id><pub-id pub-id-type="pmid">14682359</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polymenidou</surname> <given-names>M</given-names></name><name><surname>Lagier-Tourenne</surname> <given-names>C</given-names></name><name><surname>Hutt</surname> <given-names>KR</given-names></name><name><surname>Huelga</surname> <given-names>SC</given-names></name><name><surname>Moran</surname> <given-names>J</given-names></name><name><surname>Liang</surname> <given-names>TY</given-names></name><name><surname>Ling</surname> <given-names>SC</given-names></name><name><surname>Sun</surname> <given-names>E</given-names></name><name><surname>Wancewicz</surname> <given-names>E</given-names></name><name><surname>Mazur</surname> <given-names>C</given-names></name><name><surname>Kordasiewicz</surname> <given-names>H</given-names></name><name><surname>Sedaghat</surname> <given-names>Y</given-names></name><name><surname>Donohue</surname> <given-names>JP</given-names></name><name><surname>Shiue</surname> <given-names>L</given-names></name><name><surname>Bennett</surname> <given-names>CF</given-names></name><name><surname>Yeo</surname> <given-names>GW</given-names></name><name><surname>Cleveland</surname> <given-names>DW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43</article-title><source>Nature Neuroscience</source><volume>14</volume><fpage>459</fpage><lpage>468</lpage><pub-id pub-id-type="doi">10.1038/nn.2779</pub-id><pub-id pub-id-type="pmid">21358643</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radonić</surname> <given-names>A</given-names></name><name><surname>Thulke</surname> <given-names>S</given-names></name><name><surname>Mackay</surname> <given-names>IM</given-names></name><name><surname>Landt</surname> <given-names>O</given-names></name><name><surname>Siegert</surname> <given-names>W</given-names></name><name><surname>Nitsche</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Guideline to reference gene selection for quantitative real-time PCR</article-title><source>Biochemical and Biophysical Research Communications</source><volume>313</volume><fpage>856</fpage><lpage>862</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2003.11.177</pub-id><pub-id pub-id-type="pmid">14706621</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenbluth</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Multiple functions of the paranodal junction of myelinated nerve fibers</article-title><source>Journal of Neuroscience Research</source><volume>87</volume><fpage>3250</fpage><lpage>3258</lpage><pub-id pub-id-type="doi">10.1002/jnr.22013</pub-id><pub-id pub-id-type="pmid">19224642</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rot</surname> <given-names>G</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Huppertz</surname> <given-names>I</given-names></name><name><surname>Modic</surname> <given-names>M</given-names></name><name><surname>Lenče</surname> <given-names>T</given-names></name><name><surname>Hallegger</surname> <given-names>M</given-names></name><name><surname>Haberman</surname> <given-names>N</given-names></name><name><surname>Curk</surname> <given-names>T</given-names></name><name><surname>von Mering</surname> <given-names>C</given-names></name><name><surname>Ule</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>High-resolution RNA maps suggest common principles of splicing and polyadenylation regulation by TDP-43</article-title><source>Cell Reports</source><volume>19</volume><fpage>1056</fpage><lpage>1067</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.04.028</pub-id><pub-id pub-id-type="pmid">28467899</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salzer</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Polarized domains of myelinated axons</article-title><source>Neuron</source><volume>40</volume><fpage>297</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(03)00628-7</pub-id><pub-id pub-id-type="pmid">14556710</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salzer</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Schwann cell myelination</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>7</volume><elocation-id>a020529</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a020529</pub-id><pub-id pub-id-type="pmid">26054742</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sephton</surname> <given-names>CF</given-names></name><name><surname>Good</surname> <given-names>SK</given-names></name><name><surname>Atkin</surname> <given-names>S</given-names></name><name><surname>Dewey</surname> <given-names>CM</given-names></name><name><surname>Mayer</surname> <given-names>P</given-names></name><name><surname>Herz</surname> <given-names>J</given-names></name><name><surname>Yu</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>TDP-43 is a developmentally regulated protein essential for early embryonic development</article-title><source>Journal of Biological Chemistry</source><volume>285</volume><fpage>6826</fpage><lpage>6834</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.061846</pub-id><pub-id pub-id-type="pmid">20040602</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname> <given-names>X</given-names></name><name><surname>Chiang</surname> <given-names>PM</given-names></name><name><surname>Price</surname> <given-names>DL</given-names></name><name><surname>Wong</surname> <given-names>PC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice</article-title><source>PNAS</source><volume>107</volume><fpage>16325</fpage><lpage>16330</lpage><pub-id pub-id-type="doi">10.1073/pnas.1003459107</pub-id><pub-id pub-id-type="pmid">20736350</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siems</surname> <given-names>SB</given-names></name><name><surname>Jahn</surname> <given-names>O</given-names></name><name><surname>Eichel</surname> <given-names>MA</given-names></name><name><surname>Kannaiyan</surname> <given-names>N</given-names></name><name><surname>Wu</surname> <given-names>LMN</given-names></name><name><surname>Sherman</surname> <given-names>DL</given-names></name><name><surname>Kusch</surname> <given-names>K</given-names></name><name><surname>Hesse</surname> <given-names>D</given-names></name><name><surname>Jung</surname> <given-names>RB</given-names></name><name><surname>Fledrich</surname> <given-names>R</given-names></name><name><surname>Sereda</surname> <given-names>MW</given-names></name><name><surname>Rossner</surname> <given-names>MJ</given-names></name><name><surname>Brophy</surname> <given-names>PJ</given-names></name><name><surname>Werner</surname> <given-names>HB</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Proteome profile of peripheral myelin in healthy mice and in a neuropathy model</article-title><source>eLife</source><volume>9</volume><elocation-id>e51406</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.51406</pub-id><pub-id pub-id-type="pmid">32130108</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stierli</surname> <given-names>S</given-names></name><name><surname>Napoli</surname> <given-names>I</given-names></name><name><surname>White</surname> <given-names>IJ</given-names></name><name><surname>Cattin</surname> <given-names>A-L</given-names></name><name><surname>Monteza Cabrejos</surname> <given-names>A</given-names></name><name><surname>Garcia Calavia</surname> <given-names>N</given-names></name><name><surname>Malong</surname> <given-names>L</given-names></name><name><surname>Ribeiro</surname> <given-names>S</given-names></name><name><surname>Nihouarn</surname> <given-names>J</given-names></name><name><surname>Williams</surname> <given-names>R</given-names></name><name><surname>Young</surname> <given-names>KM</given-names></name><name><surname>Richardson</surname> <given-names>WD</given-names></name><name><surname>Lloyd</surname> <given-names>AC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The regulation of the homeostasis and regeneration of peripheral nerve is distinct from the CNS and independent of a stem cell population</article-title><source>Development</source><volume>145</volume><elocation-id>dev170316</elocation-id><pub-id pub-id-type="doi">10.1242/dev.170316</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stolt</surname> <given-names>CC</given-names></name><name><surname>Wegner</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Schwann cells and their transcriptional network: evolution of key regulators of peripheral myelination</article-title><source>Brain Research</source><volume>1641</volume><fpage>101</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2015.09.025</pub-id><pub-id pub-id-type="pmid">26423937</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Susuki</surname> <given-names>K</given-names></name><name><surname>Raphael</surname> <given-names>AR</given-names></name><name><surname>Ogawa</surname> <given-names>Y</given-names></name><name><surname>Stankewich</surname> <given-names>MC</given-names></name><name><surname>Peles</surname> <given-names>E</given-names></name><name><surname>Talbot</surname> <given-names>WS</given-names></name><name><surname>Rasband</surname> <given-names>MN</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Schwann cell spectrins modulate peripheral nerve myelination</article-title><source>PNAS</source><volume>108</volume><fpage>8009</fpage><lpage>8014</lpage><pub-id pub-id-type="doi">10.1073/pnas.1019600108</pub-id><pub-id pub-id-type="pmid">21518878</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Susuki</surname> <given-names>K</given-names></name><name><surname>Chang</surname> <given-names>KJ</given-names></name><name><surname>Zollinger</surname> <given-names>DR</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Ogawa</surname> <given-names>Y</given-names></name><name><surname>Eshed-Eisenbach</surname> <given-names>Y</given-names></name><name><surname>Dours-Zimmermann</surname> <given-names>MT</given-names></name><name><surname>Oses-Prieto</surname> <given-names>JA</given-names></name><name><surname>Burlingame</surname> <given-names>AL</given-names></name><name><surname>Seidenbecher</surname> <given-names>CI</given-names></name><name><surname>Zimmermann</surname> <given-names>DR</given-names></name><name><surname>Oohashi</surname> <given-names>T</given-names></name><name><surname>Peles</surname> <given-names>E</given-names></name><name><surname>Rasband</surname> <given-names>MN</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Three mechanisms assemble central nervous system nodes of Ranvier</article-title><source>Neuron</source><volume>78</volume><fpage>469</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.03.005</pub-id><pub-id pub-id-type="pmid">23664614</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Susuki</surname> <given-names>K</given-names></name><name><surname>Zollinger</surname> <given-names>DR</given-names></name><name><surname>Chang</surname> <given-names>KJ</given-names></name><name><surname>Zhang</surname> <given-names>C</given-names></name><name><surname>Huang</surname> <given-names>CY</given-names></name><name><surname>Tsai</surname> <given-names>CR</given-names></name><name><surname>Galiano</surname> <given-names>MR</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Benusa</surname> <given-names>SD</given-names></name><name><surname>Yermakov</surname> <given-names>LM</given-names></name><name><surname>Griggs</surname> <given-names>RB</given-names></name><name><surname>Dupree</surname> <given-names>JL</given-names></name><name><surname>Rasband</surname> <given-names>MN</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Glial βII spectrin contributes to paranode formation and maintenance</article-title><source>Journal of Neuroscience</source><volume>38</volume><fpage>6063</fpage><lpage>6075</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3647-17.2018</pub-id><pub-id pub-id-type="pmid">29853631</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tait</surname> <given-names>S</given-names></name><name><surname>Gunn-Moore</surname> <given-names>F</given-names></name><name><surname>Collinson</surname> <given-names>JM</given-names></name><name><surname>Huang</surname> <given-names>J</given-names></name><name><surname>Lubetzki</surname> <given-names>C</given-names></name><name><surname>Pedraza</surname> <given-names>L</given-names></name><name><surname>Sherman</surname> <given-names>DL</given-names></name><name><surname>Colman</surname> <given-names>DR</given-names></name><name><surname>Brophy</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>An oligodendrocyte cell adhesion molecule at the site of assembly of the paranodal axo-glial junction</article-title><source>Journal of Cell Biology</source><volume>150</volume><fpage>657</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1083/jcb.150.3.657</pub-id><pub-id pub-id-type="pmid">10931875</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tann</surname> <given-names>JY</given-names></name><name><surname>Wong</surname> <given-names>LW</given-names></name><name><surname>Sajikumar</surname> <given-names>S</given-names></name><name><surname>Ibáñez</surname> <given-names>CF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Abnormal TDP-43 function impairs activity-dependent BDNF secretion, synaptic plasticity, and cognitive behavior through altered sortilin splicing</article-title><source>EMBO Journal</source><volume>38</volume><elocation-id>e100989</elocation-id><pub-id pub-id-type="doi">10.15252/embj.2018100989</pub-id><pub-id pub-id-type="pmid">30692134</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tollervey</surname> <given-names>JR</given-names></name><name><surname>Curk</surname> <given-names>T</given-names></name><name><surname>Rogelj</surname> <given-names>B</given-names></name><name><surname>Briese</surname> <given-names>M</given-names></name><name><surname>Cereda</surname> <given-names>M</given-names></name><name><surname>Kayikci</surname> <given-names>M</given-names></name><name><surname>König</surname> <given-names>J</given-names></name><name><surname>Hortobágyi</surname> <given-names>T</given-names></name><name><surname>Nishimura</surname> <given-names>AL</given-names></name><name><surname>Zupunski</surname> <given-names>V</given-names></name><name><surname>Patani</surname> <given-names>R</given-names></name><name><surname>Chandran</surname> <given-names>S</given-names></name><name><surname>Rot</surname> <given-names>G</given-names></name><name><surname>Zupan</surname> <given-names>B</given-names></name><name><surname>Shaw</surname> <given-names>CE</given-names></name><name><surname>Ule</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Characterizing the RNA targets and position-dependent splicing regulation by TDP-43</article-title><source>Nature Neuroscience</source><volume>14</volume><fpage>452</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1038/nn.2778</pub-id><pub-id pub-id-type="pmid">21358640</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velebit</surname> <given-names>J</given-names></name><name><surname>Horvat</surname> <given-names>A</given-names></name><name><surname>Smolič</surname> <given-names>T</given-names></name><name><surname>Prpar Mihevc</surname> <given-names>S</given-names></name><name><surname>Rogelj</surname> <given-names>B</given-names></name><name><surname>Zorec</surname> <given-names>R</given-names></name><name><surname>Vardjan</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Astrocytes with TDP-43 inclusions exhibit reduced noradrenergic cAMP and Ca<sup>2+</sup> signaling and dysregulated cell metabolism</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>6003</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-62864-5</pub-id><pub-id pub-id-type="pmid">32265469</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Ho</surname> <given-names>WY</given-names></name><name><surname>Lim</surname> <given-names>K</given-names></name><name><surname>Feng</surname> <given-names>J</given-names></name><name><surname>Tucker-Kellogg</surname> <given-names>G</given-names></name><name><surname>Nave</surname> <given-names>KA</given-names></name><name><surname>Ling</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cell-autonomous requirement of TDP-43, an ALS/FTD signature protein, for oligodendrocyte survival and myelination</article-title><source>PNAS</source><volume>115</volume><fpage>E10941</fpage><lpage>E10950</lpage><pub-id pub-id-type="doi">10.1073/pnas.1809821115</pub-id><pub-id pub-id-type="pmid">30373824</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>LS</given-names></name><name><surname>Cheng</surname> <given-names>WC</given-names></name><name><surname>Shen</surname> <given-names>CK</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice</article-title><source>Journal of Biological Chemistry</source><volume>287</volume><fpage>27335</fpage><lpage>27344</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.359000</pub-id><pub-id pub-id-type="pmid">22718760</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>A</given-names></name><name><surname>Desmazieres</surname> <given-names>A</given-names></name><name><surname>Zonta</surname> <given-names>B</given-names></name><name><surname>Melrose</surname> <given-names>S</given-names></name><name><surname>Campbell</surname> <given-names>G</given-names></name><name><surname>Mahad</surname> <given-names>D</given-names></name><name><surname>Li</surname> <given-names>Q</given-names></name><name><surname>Sherman</surname> <given-names>DL</given-names></name><name><surname>Reynolds</surname> <given-names>R</given-names></name><name><surname>Brophy</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Neurofascin 140 is an embryonic neuronal neurofascin isoform that promotes the assembly of the node of Ranvier</article-title><source>Journal of Neuroscience</source><volume>35</volume><fpage>2246</fpage><lpage>2254</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3552-14.2015</pub-id><pub-id pub-id-type="pmid">25653379</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zonta</surname> <given-names>B</given-names></name><name><surname>Tait</surname> <given-names>S</given-names></name><name><surname>Melrose</surname> <given-names>S</given-names></name><name><surname>Anderson</surname> <given-names>H</given-names></name><name><surname>Harroch</surname> <given-names>S</given-names></name><name><surname>Higginson</surname> <given-names>J</given-names></name><name><surname>Sherman</surname> <given-names>DL</given-names></name><name><surname>Brophy</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Glial and neuronal isoforms of neurofascin have distinct roles in the assembly of nodes of Ranvier in the central nervous system</article-title><source>Journal of Cell Biology</source><volume>181</volume><fpage>1169</fpage><lpage>1177</lpage><pub-id pub-id-type="doi">10.1083/jcb.200712154</pub-id><pub-id pub-id-type="pmid">18573915</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zonta</surname> <given-names>B</given-names></name><name><surname>Desmazieres</surname> <given-names>A</given-names></name><name><surname>Rinaldi</surname> <given-names>A</given-names></name><name><surname>Tait</surname> <given-names>S</given-names></name><name><surname>Sherman</surname> <given-names>DL</given-names></name><name><surname>Nolan</surname> <given-names>MF</given-names></name><name><surname>Brophy</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A critical role for neurofascin in regulating action potential initiation through maintenance of the axon initial segment</article-title><source>Neuron</source><volume>69</volume><fpage>945</fpage><lpage>956</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.02.021</pub-id><pub-id pub-id-type="pmid">21382554</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.64456.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Bergles</surname><given-names>Dwight E</given-names></name><role>Reviewing Editor</role><aff><institution>Johns Hopkins University School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Giger</surname><given-names>Roman J</given-names></name><role>Reviewer</role><aff><institution>University of Michigan School of Medicine</institution><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Salzer</surname><given-names>James</given-names> </name><role>Reviewer</role><aff><institution>NYU</institution><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Wong</surname><given-names>Phil</given-names> </name><role>Reviewer</role><aff><institution>JHMI</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>During development, selective deletion of TDP-43 from Schwann cells revealed a cell-autonomous function in paranodal junction assembly and motor nerve conduction, but not formation of compact myelin. Mechanistic studies identified that the production of the glia-specific splice form of <italic>Nfasc</italic> (encoding NF155) is reduced, while the neuronal splice form encoding NF186 is unaltered. While it is likely that TDP-43 affects additional transcripts in Schwann cells, this study reveals one key protein that is altered as a consequence of TDP-43 deletion. As loss of TDP-43 function is associated with numerous disease and injury states, the studies have important implications for the consequences of these changes in Schwann cells.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;TDP-43 maximizes nerve conduction velocity by repressing a cryptic exon for paranodal junction assembly in Schwann cells&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Gary Westbrook as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Roman Giger (Reviewer #1); James Salzer (Reviewer #2); Phil Wong (Reviewer #3). The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, we are asking editors to accept without delay manuscripts, like yours, that they judge can stand as <italic>eLife</italic> papers without additional data, even if they feel that they would make the manuscript stronger. Thus the revisions requested below only address clarity and presentation.</p><p>Summary:</p><p>This study describes the consequences of selective deletion of the of the RNA binding protein TDP-43 from Schwann cells. Using in vivo genetic manipulations in mice, the authors show that TDP-43 is required for both the formation and maintenance of paranodal junctions in the peripheral nervous system. TDP-43 is known to suppress the incorporation of cryptic exons in diverse mRNAs. In Schwann cells lacking TDP-43 they find that inclusion of a cryptic exon in <italic>Nfasc</italic> mRNA (which encodes the paranodal protein NF155) results in a premature stop codon, triggering nonsense-mediated decay of its mRNA. The absence of this protein provides an explanation for the altered assembly of paranodal junctions, the marked delay in peripheral nerve conduction and associated motor discoordination. Nuclear exclusion of TDP-43 occurs in many cell types following injury and progressive disease, raising the possibility that Schwann cell dysfunction may also contribute to pathological changes during these conditions.</p><p>Essential revisions:</p><p>1) Provide information about the characteristics of axons and myelin in the Tardbp cko mice (g-ratio, axon diameters, etc). Changes in these features could also affect conduction velocities and contribute to paranodal defects. This is particularly important, given the large number of potential mRNA targets of TDP-43 and the observation that myelination is delayed in the conditional mutants, a phenomenon not normally observed in paranodal mutants. If this analysis is not possible in a reasonable time frame, please describe in detail the observations that can be made from existing electron micrographs and revise the text to discuss how alterations in other aspects of these myelinated nerves could contribute to the phenotypes exhibited by the Tardbp cKO mice.</p><p>2) Revise Figure 1. It is difficult to appreciate that TDP-43 is present in normal Schwann cells without displaying the Sox10 channel alone. Quantification of overlap should be provided, along with evidence that nuclear TDP-43 in non-Schwann cells was not affected by this manipulation. In Figure 1A it appears that Sox10 is strongly upregulated in cKO nerves. If this is the case, provide quantification, if not, replace figure panel with a more representative example (or single channel images). Dhh-Cre is active in endoneurial fibroblast precursors (Joseph et al., 2004), so it is unclear what cell type persistently express TDP43 in the P28 Dhh-Cre cKOs. The quality of the images of isolated nerves in panel D could be improved.</p><p>3) Revise the discussion of TDP-43 splicing repression in human Schwann cells. The lack of conservation between cryptic exons between species make this hypothesis very speculative. It would enhance the impact of the study to search available databases for evidence in humans of TDP-43 targets related to paranodal junction genes. Such human data would provide strong clinical implications of findings from this manuscript. It is possible that other TDP-43 targets related to paranodal junction are impacted in ALS patients. However, inclusion of these data is not deemed necessary for publication.</p><p>4) Revise Figure 2. Figure 2H: In assessing behavioral outcomes of TDP-43 cKO mice, a mild defect in rotarod test was observed and it appeared that there is a bimodal distribution where one group of mice show a deficit whereas the other group seemed normal. Can this be explained by extent of neurofascin cryptic exon inclusion or gender of mice? Is there assessment using an independent behavioral task to confirm this finding? Given the non-normal distribution, a standard t-test is not appropriate for this statistical comparison.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.64456.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) Provide information about the characteristics of axons and myelin in the Tardbp cko mice (g-ratio, axon diameters, etc). Changes in these features could also affect conduction velocities and contribute to paranodal defects. This is particularly important, given the large number of potential mRNA targets of TDP-43 and the observation that myelination is delayed in the conditional mutants, a phenomenon not normally observed in paranodal mutants. If this analysis is not possible in a reasonable time frame, please describe in detail the observations that can be made from existing electron micrographs and revise the text to discuss how alterations in other aspects of these myelinated nerves could contribute to the phenotypes exhibited by the Tardbp cKO mice.</p></disp-quote><p>We want to thank the reviewer for this important comment, as it constitutes an alternative conclusion. We have now measured the g-ratios and axon diameters from sciatic nerves of three WT and three cKO mice at P21, and the data is now presented in Figure 1—figure supplement 2. The g-ratios between the WT and cKO mice are not statistically different (p = 0.1214 by <italic>t</italic> test). The myelin thickness of the WT and cKO is comparable and does not contribute to the conduction delay along the cKO nerves. We find that the myelinated axons in the cKO tend to have smaller diameters; however, because the absence of paranodal junctions is known to cause ~40-50% conduction delay (≥ 50% delay in Caspr KO [Susuki et al., 2013], 41-42% delay in Caspr KO [Bhat et al., 2001], 41% delay in the <italic>Nfasc</italic> cKO by P0-Cre [Pillai et al., 2009]), and we observed a 52% delay in the TDP-43 cKO, we believe that the smaller axon diameter in the cKO only contributes to a small portion in the delay of nerve conduction. We have revised the manuscript to discuss this variable.</p><disp-quote content-type="editor-comment"><p>2) Revise Figure 1. It is difficult to appreciate that TDP-43 is present in normal Schwann cells without displaying the Sox10 channel alone. Quantification of overlap should be provided, along with evidence that nuclear TDP-43 in non-Schwann cells was not affected by this manipulation. In Figure 1A it appears that Sox10 is strongly upregulated in cKO nerves. If this is the case, provide quantification, if not, replace figure panel with a more representative example (or single channel images). Dhh-Cre is active in endoneurial fibroblast precursors (Joseph et al., 2004), so it is unclear what cell type persistently express TDP43 in the P28 Dhh-Cre cKOs. The quality of the images of isolated nerves in panel D could be improved.</p></disp-quote><p>We now include the single-channel images for TDP-43 and Sox10 from P28 in Figure 1—figure supplement 1, together with those from P3. All the Sox10-positive nuclei are TDP-43-positive in the WT. The intensity of Sox10 staining varies among different nuclei of the WT and cKO especially at P28, and we did not observe a change in the Sox10 levels in the cKO.</p><p>We thank the reviewers for bringing our attention to the study by Joseph et al., 2004. We observed the complete loss of paranodal junctions in the PNS using three different Cre driver lines to conditionally knock out TDP-43 in our study—Dhh-Cre, P0-Cre and Cnp-Cre—and this strongly indicates that the phenotype we observe is cell-autonomous to Schwann cells. Furthermore, we have stained the endoneurial fibroblasts with PDGFRα and confirmed that the fibroblasts are among the TDP-43-positive/Sox10-negative population in the cKO mice (by Dhh-Cre), which includes other PDGFRα-negative, non-fibroblast cells as well (Figure 1—figure supplement 1C). The apparent discrepancy between our observation and that of Joseph et al. with the Dhh-Cre in endoneurial fibroblasts may be attributed to the different floxed alleles involved. This has been shown to be the case for Cnp-Cre (Tognatta et al., 2017 [PMID: 27807896] showed that the recombination events by Cnp-Cre in neurons or astrocytes are restricted to specific reporter alleles). In brief, when combining the Tardbp floxed allele and Dhh-Cre, we do not observe recombination in endoneurial fibroblasts.</p><p>We have changed panel D of Figure 1 to improve the picture quality.</p><disp-quote content-type="editor-comment"><p>3) Revise the discussion of TDP-43 splicing repression in human Schwann cells. The lack of conservation between cryptic exons between species make this hypothesis very speculative. It would enhance the impact of the study to search available databases for evidence in humans of TDP-43 targets related to paranodal junction genes. Such human data would provide strong clinical implications of findings from this manuscript. It is possible that other TDP-43 targets related to paranodal junction are impacted in ALS patients. However, inclusion of these data is not deemed necessary for publication.</p></disp-quote><p>We have analyzed the human TDP-43 CLIP-seq dataset by Tollervey et al., 2011, and found several potential TDP-43-binding sites on human <italic>NFASC</italic> pre-mRNA (see <xref ref-type="fig" rid="respfig1">Author response image 1</xref>). At first glance, the binding sites for TDP-43 in humans are distinct from mice, but the human dataset has a much lower coverage than the mouse; therefore, further experiments are needed to provide a comprehensive view on whether TDP-43 binds to <italic>NFASC</italic> transcripts and regulates <italic>NFASC</italic> expression in human Schwann cells. We believe that this is a really important point but is beyond the scope of our current study. We anticipate that future investigation with human Schwann cells will be exceedingly interesting and will help determine the relevance of our study to the human condition.</p><fig id="respfig1"><label>Author response image 1.</label><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-64456-resp-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>4) Revise Figure 2. Figure 2H: In assessing behavioral outcomes of TDP-43 cKO mice, a mild defect in rotarod test was observed and it appeared that there is a bimodal distribution where one group of mice show a deficit whereas the other group seemed normal. Can this be explained by extent of neurofascin cryptic exon inclusion or gender of mice? Is there assessment using an independent behavioral task to confirm this finding? Given the non-normal distribution, a standard t-test is not appropriate for this statistical comparison.</p></disp-quote><p>The complete loss of paranodal junctions has been confirmed in at least two cKO mice per Cre driver line (we used three Cre driver lines: Dhh-Cre, P0-Cre and Cnp-Cre), and the paranodal phenotype has a 100% penetrance. We have included more mice in the rotarod analysis for a total of 10 mice per genotype. The cKO data points are now more evenly distributed (revised Figure 2H), and the normality of the data point distribution is not rejected by the Shapiro-Wilk test (p = 0.1513 for 24 rpm and p = 0.1949 for 32 rpm). The majority of the WT mice could remain on the rotating rod until the cutoff time of 90 sec and indeed the normality of the WT distribution is rejected by the Shapiro-Wilk test. Therefore, we have switched to the Mann-Whitney statistical analysis and now present the data in box-and-whisker plots. The motor deficit of the cKO mice is now confirmed with a larger group of mice and by using the Mann-Whitney test (p = 0.0115 for 24 rpm and p = 0.0036 for 32 rpm). We have revised the manuscript and source data file accordingly.</p></body></sub-article></article>